The Kalshi market prices this at 65% with very limited trading data (1 day, 500 contracts average). Beam Therapeutics' risto-cel is a base-editing therapy for sickle cell disease that has shown promising clinical results. The timeline to April 2027 gives roughly 2 years from now for a BLA submission. Key considerations: BLA submissions for gene/cell therapies often face delays due to manufacturing complexity, CMC requirements, and the need for sufficient follow-up data. Beam has been progressing risto-cel through trials but hasn't yet announced a definitive BLA submission timeline. The market price of 65% seems reasonable given the uncertainty around manufacturing scale-up and regulatory readiness. Without specific recent news articles to provide new information, I'll anchor close to the market price but shade slightly lower (63%) given the general tendency for biotech regulatory timelines to slip and the thin trading volume suggesting this price may not be well-established.

The Kalshi market shows 42% probability, but this appears to be a thinly traded market (190 contracts/day average) that is likely significantly overpriced relative to the true probability. Martial law has never been formally declared nationwide in U.S. history. The evidence strongly points against it: federal courts are actively blocking even National Guard deployments as unlawful, the Supreme Court is checking executive overreach on multiple fronts, military leadership is actively resisting domestic deployment, Trump moderated his tone on deportations due to political backlash, and critics assume he will leave office through normal means. While Trump has pushed boundaries with National Guard deployments and Insurrection Act rhetoric, every article points to institutional resistance (courts, military brass, Congress to some degree) preventing escalation to martial law. The 42% Kalshi price likely reflects speculative/partisan trading rather than calibrated probability assessment. Historically, even during the Civil War, World War II, and major domestic crises, martial law was only declared in limited geographic areas, never as a sweeping national measure. I deviate sharply from the market price because the base rate is essentially zero and the evidence uniformly points toward institutional checks functioning.

The 25th Amendment Section IV has never been invoked in American history. It requires the VP and a majority of the Cabinet to declare the President unable to discharge duties — an extraordinarily high political bar. All evidence shows Vance is deeply loyal to Trump, actively mediating disputes and maintaining lockstep alignment while positioning for 2028 (which requires Trump's base support). The Republican Congress is highly deferential to Trump. Trump appears fully engaged — delivering State of the Union addresses, conducting lengthy interviews, and making major policy decisions. The Kalshi market at 33% seems dramatically overpriced relative to fundamentals; this appears to be a novelty/meme market where retail traders overweight dramatic scenarios. The base rate for 25th Amendment Section IV invocation across all presidencies is 0%, and there is zero evidence of any movement in this direction. I deviate significantly downward from the market price because the political prerequisites (disloyal VP, disloyal Cabinet majority, actual incapacity) are essentially absent, and the 3.5 years remaining don't change the calculus meaningfully given current conditions.

The Kalshi market prices this at 32%, with a significant +18% move in the last 7 days suggesting new information or sentiment shift toward departure. However, all available article evidence through early March 2026 points strongly toward Bondi remaining in her role — she's actively defending her position, testifying combatively before Congress, and exercising her authority as AG. The Noem ouster precedent shows Trump will remove Cabinet members who become liabilities, which could explain some market concern. The related market on Trump having only 1 AG (32%) is consistent with the main market. The sharp recent price increase without corresponding news evidence in my research suggests either the market is responding to information I don't have, or it's overshooting on speculation. I'll shade slightly below the market price at 30%, respecting the market signal but noting that the factual evidence uniformly suggests Bondi is staying. The remaining ~13 months until resolution is a long time, but the question asks about before May 2026 (about 2 months from the latest data), which is a shorter window where departure requires rapid action.

The Kalshi market prices this at 67% with a strong upward move of +15% over the past week, though based on only 5 data points and moderate volume (177 contracts/day). The evidence broadly supports elevated NYC rent growth: NYC has seen the largest rent increases since 2020, supply constraints remain severe, housing inflation is persistent nationally, and political efforts (Mamdani's rent freeze) only target stabilized units, not the market-rate sector tracked by StreetEasy. However, national multifamily rent trends are moderating (even declining 0.8% nationally), and December 2026 is 18+ months away, introducing substantial uncertainty. The StreetEasy Rent Index for all bedrooms would need to sustain >4% YoY growth through a period where national trends are cooling, though NYC has historically outperformed national averages due to unique supply constraints. I slightly discount from the market price to 65% given the thin trading history and the long time horizon with potential for economic slowdown or policy changes that could moderate growth.

The Kalshi market prices Ramp IPO before June 2027 at 22%, with a notable downward trend (-12% over 7 days, -21% over 30 days), suggesting declining confidence. Ramp has not publicly announced IPO plans, and there's no specific news indicating imminent filing. The related Ramp vs Brex market shows Brex at only 2% to IPO first, which is consistent with neither company being close to IPO. Navan's IPO and subsequent 20% stock drop may actually discourage Ramp from rushing to market. The IPO environment in early 2026 appears mixed with debt issuance dominating. Given the strong downward price momentum and lack of any concrete IPO signals, I shade slightly below the current market price at 19%.

The Kalshi market prices this at 22% with a downward trend (-6% over 7 days). The evidence supports a lower probability: Beast Industries raised $200M in private capital in January 2026, suggesting they're still in private fundraising mode rather than preparing for an IPO. There are no reports of IPO filings, roadshows, or public listing intentions. The insider trading scandal involving a Beast Industries employee on Kalshi adds reputational complexity that could further delay any IPO timeline. With less than a year remaining until the March 2027 deadline and no concrete IPO signals, I shade slightly below the market price to 18%, reflecting both the market's declining sentiment and the lack of any positive IPO indicators.

The Kalshi market prices this at 30% with a notable +20% move over the past 30 days, though volume is relatively low (92 contracts/day over only 13 days of data). The evidence strongly supports headwinds for US solar installations in 2026: Trump administration actively blocking large-scale solar projects (canceling the 6.2 GW Esmeralda project), tariffs on Chinese goods increasing solar component costs, and supply chain disruptions. For context, the US installed roughly 33-40 GWdc in recent years, and reaching 55 GWdc would require a massive jump even without these headwinds. While there are some positive signals (MAGA allies warming to solar, growing DIY adoption), these are insufficient to overcome the structural barriers. The 55 GWdc threshold is quite ambitious and the policy environment is actively hostile. I'm slightly below the market price at 28%, as the evidence suggests the recent upward price movement may be somewhat optimistic given the concrete policy obstacles documented.

The Kalshi market prices this at 9%, which I find roughly appropriate but perhaps slightly generous. The question requires Musk to personally visit Mars before his death or 2099. Key considerations: (1) Musk was born in 1971, so he'd be 127 by 2099 - realistically he has maybe 30-40 years of life remaining, giving a window until roughly 2055-2065. (2) SpaceX has recently pivoted priority to the Moon over Mars, with Mars city-building pushed 5-7 years out. (3) Starship is still in early development with major unsolved challenges (orbital refueling, life support, radiation shielding for 6+ month journey). (4) Even if humans reach Mars by 2040s-2050s, sending Musk personally (rather than trained astronauts) adds another layer of difficulty - he'd need to be healthy enough and willing to risk a ~2-year round trip. (5) The related market gives only 29% chance of ANY human landing on Mars before 2050, and colonization before 2050 at ~20%. Musk personally going is a strict subset of humans going at all, and requires him to be alive and healthy. I shade slightly below the market price at 8%, as the evidence consistently points to delays and the personal visit requirement is very restrictive.

The Kalshi market prices this at 66%, which I'll use as my anchor. The evidence supports Blue Origin having a plausible path to landing an uncrewed Blue Moon MK1 before SpaceX lands an uncrewed Starship on the Moon. Key factors favoring YES: (1) Blue Origin paused New Shepard tourism to focus on lunar capabilities, showing prioritization; (2) NASA's acting administrator explicitly suggested Blue Origin could be used for Artemis III if SpaceX falls behind; (3) SpaceX Starship faces enormous technical hurdles including orbital refueling that has never been attempted, and has had failures in 6 of 10 test flights. Key factors favoring NO: (1) Musk pivoted SpaceX priority to the Moon, potentially accelerating their timeline; (2) SpaceX has a faster development cadence and more launch experience; (3) Blue Moon MK1 has not yet flown at all, so it faces its own development risks. The question is specifically about uncrewed landings - Blue Moon MK1 is a smaller, simpler vehicle compared to Starship's lunar variant, which requires multiple refueling flights. However, Blue Origin also has a less proven track record with complex missions. I shade slightly below the market at 64% because SpaceX's recent momentum (successful Flight 11, Musk's Moon pivot) may slightly narrow Blue Origin's advantage, though the fundamental complexity gap between the two vehicles still favors Blue Origin arriving first.

The Kalshi market prices the US at 68% to send humans to the Moon before Jan 1, 2031. The evidence strongly supports this: Artemis II launched (or is launching) on April 1, 2026, sending astronauts around the Moon — though this is a flyby, not a landing. The question asks about sending humans 'to the Moon,' which could be interpreted as either a flyby or landing. If a flyby counts, the probability should be much higher given Artemis II is essentially happening now. However, the market at 68% suggests participants interpret this as requiring a landing. For a landing, NASA restructured Artemis to target 2028, with significant uncertainty around Starship readiness and lander development. China targets 2030 but faces its own uncertainties. The US has the most advanced program, $20B+ in investment, multiple lander options (SpaceX, Blue Origin), and strong political will driven by competition with China. I slightly nudge above the market price to 70% given the confirmed Artemis II success demonstrating SLS/Orion capability, SpaceX's pivot to lunar focus, and NASA's plan for two landings in 2028, while acknowledging substantial technical risk in the lander development timeline.

The Kalshi market prices Judy Shelton at 1.8%, and the evidence strongly supports this low probability. Trump has already nominated Kevin Warsh as Fed chair to replace Powell, directly precluding Shelton. While Warsh's confirmation is being delayed by Sen. Tillis's hold, the path to Shelton becoming chair would require Warsh's nomination to fail AND Trump to then pivot to Shelton rather than another candidate — a very unlikely chain of events. No recent reporting mentions Shelton as a candidate. I place my estimate at 2%, very slightly above the market price to account for small tail scenarios where Warsh fails and Trump circles back to Shelton, but this remains extremely unlikely.

The Kalshi market prices this at 11.7%, but the evidence strongly points toward NO. Every single article confirms the bill faces insurmountable obstacles in the Senate: Democrats are unified in opposition, Republicans lack 60 votes to overcome the filibuster, and Senate leadership has repeatedly confirmed they don't have the votes to change filibuster rules. The bill already went through a performative marathon debate in March 2026 that was 'all but certain to fail.' Trump's threat to block other legislation until the SAVE Act passes hasn't changed the math. With the 117th Congress ending Jan 3, 2027, time is running out and no pathway to 60 votes or filibuster reform has materialized. I'm pricing this below the market at ~6% because the market may be slightly overpricing the tail risk of a filibuster rule change or some unexpected compromise, but the evidence is overwhelmingly against passage.

Capital One announced it is acquiring Brex for $5.15 billion in January 2026, meaning Brex will be absorbed into Capital One rather than pursuing an independent IPO. This effectively eliminates the possibility of Brex IPO-ing first (or at all). The Kalshi market already reflects this at 2%, which is appropriate — the small residual probability accounts for the unlikely scenario that the acquisition falls through (regulatory block, deal collapse) AND Brex then IPOs before Ramp does. Given that the deal has been publicly confirmed by both parties, the chance of it failing is small, and even if it did fail, Brex would still need to IPO before Ramp. The 2% market price seems well-calibrated.

The Kalshi market prices Anthropic IPOing first at 65%, but the evidence strongly suggests otherwise. OpenAI is actively preparing for an IPO with prospectus-like documents shared with investors, a $730B valuation, $13.1B in 2025 revenue, and multiple reports indicating it could go public 'as soon as this year' (2026). Meanwhile, Anthropic faces severe headwinds: Pentagon blacklisting, costly litigation with the government, loss of hundreds of millions in contracts, and no reported IPO plans whatsoever. Every factual article points toward OpenAI being far more advanced in IPO readiness. The market's 65% for Anthropic seems mispriced given the overwhelming evidence favoring OpenAI going first. While there's a long time horizon (until 2040) allowing for reversals, OpenAI's near-term IPO timeline makes it very likely to beat Anthropic. I deviate significantly from the market price because the directional evidence is consistently and strongly against Anthropic IPOing first, and the market volume (362/day) isn't exceptionally high, suggesting potential inefficiency.

The Kalshi market prices this at 33%, but several significant developments suggest upside risk. The Iran war and oil supply disruption through the Strait of Hormuz (Brent at $119.50/barrel) represents a major stagflationary shock that historically has preceded recessions (1973, 1979, 1990). Goldman Sachs at 30% and EY-Parthenon at 40% recession probability align with elevated risk. However, the market definition requires two consecutive quarters of negative GDP growth reported by BEA, which is a stricter criterion than NBER recession dating—the economy could experience significant pain without technically meeting this threshold. The U.S. entered 2026 with solid fundamentals (low unemployment, decent growth), and even the 1990 oil shock recession was mild. I'm adjusting modestly above the Kalshi price (33%) to 38%, reflecting that the Iran war oil shock is a genuinely new and large negative supply shock that may not yet be fully priced in, but acknowledging that the two-consecutive-quarters-of-negative-GDP bar is historically difficult to clear even in adverse conditions, especially with fiscal stimulus from tax cuts partially offsetting.

The Kalshi market prices this at 87.2% with strong volume (~438K daily contracts) and a clear upward trend (+15.9% over 30 days), indicating growing confidence. The evidence strongly supports this: January 2026 alone saw 108,435 announced job cuts (highest January since 2009), with tech as the second-hardest hit sector. The 2025 baseline saw nearly 1 million total layoffs driven by AI adoption and a 'jobless boom,' and early 2026 data shows acceleration with major cuts from Amazon (16,000), Pinterest, and others. AI-driven layoffs are explicitly accelerating (55,000 attributed to AI in 2025, 12x from two years prior). Macroeconomic headwinds (recession fears, geopolitical tensions) add further upside risk to layoffs. The threshold of 447,000 information sector layoffs in 2026 appears achievable given the pace in early 2026 and structural AI displacement trends. I see no strong reason to deviate from the well-traded market price and set my estimate at 0.88, slightly above the current market reflecting the strongly directional recent evidence.

The Kalshi market prices this at 44.5%, which is my primary anchor. The related 'D-House, D-Senate' balance of power market is at 48.6%, which represents Democrats winning both chambers regardless of margin. This combo requires Democrats to win 235+ House seats specifically AND 51+ Senate seats - a higher bar than just winning both chambers. The evidence strongly supports Democrats winning the House (favorable generic ballot, special election swings, California redistricting gains, Trump disapproval), but multiple analysts emphasize the narrow battlefield makes 235+ seats difficult - that's a net gain of ~20 seats from current levels, which requires a substantial wave. The Senate map is also challenging. While Democratic enthusiasm is high, the specific threshold of 235 House seats is the binding constraint that makes this harder than just 'win both chambers.' I shade slightly below the market price to 40% because the 235-seat threshold is genuinely demanding given the narrow competitive map, even in a strong Democratic environment. The ~4 point gap between this market (44.5%) and the general D-D market (48.6%) seems about right for the additional seat threshold requirement.

The Kalshi market prices this at 90%, but the evidence overwhelmingly supports an even higher probability. Multiple factual sources from early 2026 confirm that over 300,000 federal employees have left the payroll since Trump took office, with net shrinkage of ~242,000 by December 2025. The question asks whether more than 50,000 were cut before January 2027 relative to December 2025 levels — given that massive cuts already occurred through 2025 and continued into 2026, this threshold of 50,000 additional cuts from the December 2025 baseline is almost certainly already met or will be met. The market at 90% likely reflects some residual uncertainty about resolution criteria interpretation, but the factual evidence is overwhelming. I push to 0.97 given the strong factual confirmation from multiple sources dated in early 2026.

The Kalshi market prices this at 24%, but the evidence strongly suggests this should be lower. The U.S. and Iran are in active armed conflict as of late February 2026, with massive bombing campaigns, the killing of Iran's supreme leader, and a blockade of the Strait of Hormuz. Even before the war, U.S.-Iran trade was essentially zero due to comprehensive sanctions - historical Census Bureau data shows U.S. imports from Iran have been negligible (typically well under $5M) for years. An active war makes even the tiny residual trade impossible. The only scenario for Yes would be a rapid peace deal followed by sanctions relief and resumed trade exceeding $5M in the remaining months of 2026, which is extremely unlikely given the scale of the conflict. I deviate significantly below the Kalshi price of 24% because the war evidence is overwhelming and unambiguous - this market appears overpriced, possibly due to low volume (94 contracts/day) and thin liquidity.

The Kalshi market prices this at 15%, but I believe this is inflated given the extremely low base rate for a >25bps hike at any single meeting, especially nearly two years out. Historically, the Fed almost never hikes by more than 25bps in a single meeting—even during the aggressive 2022-2023 tightening cycle, 50bp and 75bp hikes were rare and required extraordinary inflation. All research evidence points firmly against hikes: the Fed was cutting rates through 2025, inflation is near target at 2.7%, political pressure favors lower rates, and the new Fed chair nominee Warsh is described as hawkish but not aggressively so. The 30-day price drop of -29% on this contract suggests the market is already correcting toward lower probability. For a >25bps hike to occur in January 2028, we'd need a severe inflationary shock that reverses the entire current trajectory—possible but very unlikely. The low volume (71 contracts/day) suggests this price is noisy and unreliable. I deviate significantly below the market price to 5%, reflecting that while tail risks exist over a 2+ year horizon, the specific scenario of a >25bps hike is extremely improbable given current trajectory and historical precedent.

The Kalshi market prices this at 11%, but the evidence overwhelmingly points to a lower probability. The Supreme Court explicitly declined to hear the Kim Davis challenge to Obergefell in November 2025 without any noted dissent beyond Thomas. No same-sex marriage case is on the docket or pipeline for the upcoming terms. Public support is at ~68-70%, nearly a million same-sex couples are married, and Congress passed the Respect for Marriage Act in 2022. Unlike Roe, there is no organized litigation campaign building toward reversal, no circuit split, and only one justice (Thomas) has publicly called for reconsideration. Even if Thomas retires and is replaced by a more conservative justice, that doesn't create the 4+ votes needed for cert or 5 for reversal. The market at 11% likely reflects residual fear/speculation rather than any concrete legal pathway. I estimate ~3% to account for truly unforeseeable scenarios (e.g., a novel case reaching the court through an unexpected route with a dramatically changed composition), significantly below the market price which I believe is inflated.

The Kalshi market prices this at 44%, but recent evidence strongly suggests downward pressure is warranted. The key developments are: (1) Trump decoupled Saudi bilateral deals (F-35s, $1T investment) from Israel normalization, removing the main US leverage to push the deal; (2) MBS explicitly conditioned normalization on a 'path' to Palestinian statehood 'which may take many years'; (3) Netanyahu's coalition depends on far-right partners who categorically oppose Palestinian statehood; (4) The market has already dropped 7% in the past week, reflecting these dynamics. The 7-day price decline suggests the market is adjusting downward but may not have fully incorporated how fundamentally the decoupling undermines the normalization timeline. With ~3.5 years remaining, a new Israeli government (if Netanyahu falls) could theoretically create an opening, but even then Saudi Arabia's Palestinian statehood condition is a structural barrier. I estimate 30%, below the current market price, because the structural obstacles are severe and the key leverage mechanism has been removed.

The Kalshi market prices this at 33%, but I believe this significantly overestimates the probability. All available evidence through early 2026 shows the U.S. strategy is focused on removing Chinese corporate influence from canal-adjacent ports through diplomatic and legal pressure on Panama—not on taking direct governmental control. Panama's Supreme Court voided CK Hutchison's license, which the Trump administration treated as a major victory, suggesting they view this approach as sufficient. There is no reporting of any plans, military preparations, or diplomatic demands for actual U.S. control of the canal itself. Taking sovereign territory from a functioning democracy and treaty ally would be unprecedented in modern U.S. history, would face enormous legal, diplomatic, and military obstacles, and would likely trigger severe international backlash. While Trump has shown willingness to use force in the hemisphere (Venezuela/Maduro operation), the Panama Canal situation appears to be resolving favorably for U.S. interests without seizure. I deviate substantially from the Kalshi price because I believe the market is inflated by speculative interest driven by Trump's rhetoric rather than realistic assessment of actual takeover probability—the 33% price likely reflects attention bias and the novelty of the question rather than calibrated probability.

The Kalshi market prices this at 19% but has been declining sharply (-9% over 7 days, -5% over 30 days), suggesting growing skepticism. The key constraint is that formal elimination requires Congressional legislation with 60 Senate votes, which the administration clearly lacks. All evidence shows the administration is pursuing a 'hollowing out' strategy—transferring functions to other agencies, cutting staff, vacating headquarters—but explicitly acknowledges it cannot formally eliminate the department without Congress. The question asks about the department being 'sunsetted or eliminated entirely,' not merely gutted or hollowed out. Even with aggressive executive action, the department will likely continue to exist as a legal entity through January 2029. Republican Senate margins are insufficient, and there's no indication Democrats would provide the votes needed. The downward price trend on Kalshi aligns with the accumulating evidence that formal elimination is extremely unlikely. I'm going below the market at 10% because the market may still be overpricing the possibility of some creative legal pathway or Congressional deal that seems very improbable given current political dynamics.

The Kalshi market prices this at 34%, but I believe this is significantly overpriced. Every piece of evidence points strongly against a formal free trade agreement (FTA) with China becoming law before Jan 20, 2029. The key distinction is between a 'trade deal/framework/truce' (which has partially materialized as tariff reductions) and an actual 'free trade agreement' that becomes law. FTAs are comprehensive legal instruments that typically take years to negotiate and require Congressional approval. The US has never had an FTA with China, and the current environment shows: (1) only fragile tariff truces with 'a final agreement nowhere in sight' as of Dec 2025, (2) Supreme Court striking down Trump's tariff authority under IEEPA, creating legal chaos, (3) China gaining global leverage and reducing US dependency, making concessions less likely, (4) nuclear testing directives and escalating security tensions undermining diplomatic progress, and (5) no indication either side is pursuing a comprehensive FTA. Historically, US FTAs take 3-10+ years from initiation to law. The market at 34% likely conflates partial trade deals/truces with a formal FTA becoming law. I deviate sharply downward because the resolution criteria specifically requires a new free trade agreement that 'has become law' — an extraordinarily high bar given the political, legal, and geopolitical obstacles.

The Kalshi market prices this at ~25%, but I believe this overestimates the probability of an actual purchase. The related 'No Acquisition' market at 81% (and trending upward) is more informative — it directly asks whether no purchase occurs and strongly suggests the market consensus is against a deal. The 'take control' market at 34% includes non-purchase scenarios (military bases, lease agreements, etc.), which explains the gap with the purchase-specific question. All evidence points strongly against a purchase: Denmark and Greenland firmly refuse to sell, European allies are unified in opposition, even Trump advisers prefer concessions over outright purchase, the Vance meeting ended in 'fundamental disagreement,' and Greenlandic cultural identity strengthens resistance. Trump dropped tariffs after getting only 'a framework' (not a purchase deal) at Davos. For a purchase to happen, Denmark would need to agree to sell sovereign territory — something no democratic nation has done under economic pressure in modern history. The 25% Kalshi price likely reflects speculative interest and Trump's unpredictability rather than realistic probability of a completed purchase transaction. I place this well below market at ~6%, reflecting the near-impossibility of both sides agreeing to a formal purchase within the timeframe.

The Kalshi market prices this at 24%, but I believe this significantly overestimates the probability. Historical base rate: no US president has ever been impeached AND removed from office. Trump was impeached twice before and acquitted both times. The evidence strongly points against removal: (1) Republicans control both chambers currently, making even impeachment impossible before 2027; (2) Democrats are strategically avoiding impeachment talk, focusing instead on 2026 midterms; (3) Even if Democrats win the House in 2026, they would need 67 Senate votes for conviction - requiring ~16-17 Republican senators to vote to remove their own party's president, which is historically unprecedented; (4) Democratic leadership is pursuing targeted accountability (e.g., Noem impeachment) rather than presidential impeachment; (5) No smoking-gun impeachable offense has emerged that would fracture Republican loyalty. The Kalshi price at 24% seems inflated, possibly driven by speculative retail traders or conflation of 'impeachment' (House vote) with 'removal' (Senate conviction). The question requires BOTH impeachment AND conviction. Even in the most favorable scenario - Democrats take the House in 2026 and impeach - Senate conviction remains essentially impossible without a dramatic, unprecedented collapse of Republican support. I deviate substantially from the market price because the structural barriers to Senate conviction are overwhelming.

The Kalshi market prices this at 12%, but I believe this is significantly overpriced. The US acquiring any part of Canada would be an extraordinary geopolitical event with no historical precedent in modern times. Canada is a sovereign G7 nation, NATO ally, and any territorial transfer would require Canadian parliamentary/constitutional approval, which is essentially inconceivable. Even with Trump's rhetoric about making Canada the '51st state,' there is no realistic mechanism for this to happen before January 2029. The Alberta secession market at 21% is interesting but even if Alberta voted to secede (itself unlikely), it joining the US is a separate and even less likely step requiring years of constitutional and legal processes. The 12% Kalshi price likely reflects speculative/meme trading rather than genuine probability assessment. Historical base rate for sovereign democratic nations voluntarily ceding territory to another nation in peacetime is essentially zero. I deviate strongly from the market price because this falls into the category of events that prediction markets systematically overprice due to novelty and political entertainment value.

The Kalshi market for this specific question prices acquisition at 34%, but I believe this is significantly overpriced. The related 'No Acquisition' market at 81% and the 'buy' market at 24.9% both suggest lower probability. The evidence is overwhelmingly negative: high-level Vance negotiations ended in 'fundamental disagreement,' Denmark and Greenland firmly reject any sale, all of Europe has drawn red lines, Greenland's population strongly opposes it, and historical precedent shows every US attempt since 1867 has failed. Even Trump advisers are wary of military action. The only path to acquisition would be either a military invasion of a NATO ally (catastrophically unlikely) or a negotiated deal that both Denmark and Greenland reject. With under 3 years remaining, the diplomatic trajectory is moving away from any deal. The 34% Kalshi price likely reflects speculative interest and Trump's unpredictability premium, but the actual structural barriers — requiring consent of Denmark's parliament, Greenland's government, and navigating NATO implications — make acquisition extraordinarily unlikely in this timeframe. I set my estimate at 8%, acknowledging Trump's unpredictability but weighting the massive diplomatic, legal, and political obstacles heavily.

The Kalshi market prices this at 22%, but I believe this is significantly overpriced. Historical base rate: only one US president (Nixon) has ever resigned, out of 46 presidencies. All research articles from early-to-mid 2026 show Trump actively governing, giving press conferences, delivering State of the Union addresses, and showing no signs of resignation. Even under political pressure (Epstein documents, impeachment threats, health scrutiny, Supreme Court setbacks), Trump has shown a combative rather than retreating posture. Trump's personality and historical behavior strongly suggest he would fight any removal rather than resign voluntarily. The 22% market price likely reflects speculative interest and tail-risk hedging (health events, political crises) rather than genuine probability. Even accounting for ~3 more years of tail risks (health emergency, unprecedented scandal), I estimate the true probability at around 8%. The market may be inflated by low volume (~477 contracts/day) and retail speculation.

The Kalshi market prices this at 11%, but the evidence strongly suggests even that is generous. Manufacturing's share of GDP has been on a secular decline for decades (from ~13.1% in 2005 to ~11% in recent years). Reaching 13.1% would require a roughly 20% increase in manufacturing's GDP share within ~3 years - an unprecedented reversal. The research evidence is overwhelmingly negative: 83,000 manufacturing jobs lost in Trump's first year, the Supreme Court struck down his primary tariff mechanism (IEEPA), China circumvented tariffs through third countries, tariff uncertainty discouraged long-term investment, and factories take years to build even when commitments are made. With Trump's main policy tool (broad tariffs) legally constrained and no evidence of meaningful reshoring occurring, I see this as significantly below the market price. Even aggressive industrial policy would struggle to move this needle given the structural forces (automation, services economy growth, global supply chain adaptation). I'm deviating below market at 4% because the accumulated evidence from 2025-2026 shows the manufacturing revival strategy is failing on multiple fronts.

The market prices this at 15%, but I believe this is significantly too high. The question requires NO budget deficit in ANY of FY2025-2028. The current deficit is roughly $1.8-2 trillion annually. The related market shows only 6% probability of getting the deficit-to-GDP ratio even below 5% for FY2026, let alone zero. Trump is proposing a ~$500B defense spending increase, there's no serious balanced budget legislation, and the government shutdown was over healthcare subsidies not deficit reduction. Historically, the US hasn't had a balanced budget since 2001, and even then it required the dot-com boom, post-Cold War defense cuts, and bipartisan fiscal discipline. Eliminating a $1.8T deficit in 1-3 years is essentially impossible without massive spending cuts and/or tax increases that have zero political support. The 15% Kalshi price likely reflects speculative/thin trading (only 144 contracts/day average) rather than informed probability assessment. I deviate strongly downward because the mathematical and political reality makes this virtually impossible.

The Kalshi market shows 73%, but I believe this significantly overestimates the probability. EU accession is an extremely lengthy process requiring unanimous consent from all existing members, completion of 35 negotiating chapters, and ratification by all national parliaments. No country is close to completing this process by January 2030. The most advanced candidates are Montenegro and Serbia, but both face significant unresolved issues (rule of law, judiciary reforms, Serbia's Kosovo recognition). While there's been renewed political momentum for EU enlargement (especially post-Ukraine), the institutional and legal hurdles make accession by 2030 nearly impossible. Historical base rates show the last accession was Croatia in 2013, and before that the 2007 and 2004 waves - each took 8-12 years from candidacy to membership. Even with expedited political will, the technical and legal requirements cannot realistically be completed by Jan 1, 2030. The Kalshi market likely has low volume (73 contracts/day) and may be mispriced due to thin trading and confusion about the realistic timeline. I'm deviating substantially from the market price because the structural barriers to accession within this timeframe are overwhelming.

The Kalshi market prices this at 29%, but I believe this significantly overestimates the probability. The evidence is overwhelmingly negative: (1) Musk himself pivoted in Feb 2026 to prioritize the Moon, saying Mars plans would begin in 'about five to seven years' — meaning 2031-2033, well after the 2030 deadline. (2) As of late 2025, Starship had not achieved orbital propellant transfer, a prerequisite technology for Mars missions. (3) SpaceX was behind schedule even on the lunar lander contract. (4) Mars launch windows occur only every ~26 months (next windows: late 2026, early 2029), and to land before Jan 1 2030, SpaceX would need to launch by early 2029 at the latest — requiring V3 Starship to be fully operational with propellant transfer capability within ~3 years from a point where it hasn't been demonstrated once. (5) Even an uncrewed cargo landing on Mars requires entry/descent/landing technology never tested on Mars by SpaceX. The market at 29% likely reflects speculative enthusiasm rather than engineering reality. I deviate substantially downward to ~8%, reflecting the near-impossibility of the remaining technical milestones being achieved in time.

The Kalshi market price of 49.5% seems significantly overvalued given the evidence. The question requires a humanoid robot to physically walk on Mars before 2035 - roughly 9 years away. Every piece of evidence points strongly against this: (1) Starship, the only vehicle with potential Mars payload capacity, has suffered repeated explosive failures and can't even meet lunar landing timelines; (2) No space agency or company has announced any plan to send a humanoid robot to Mars; (3) Humanoid robots are still in early terrestrial factory testing phases; (4) Even getting humans back to the Moon by 2027-2030 is in serious jeopardy; (5) A Mars mission requires ~2 year transit windows, meaning a launch would need to happen by ~2033 at latest, requiring mission design, funding, and vehicle readiness years before that. The market price likely reflects speculative trading and possibly confusion about what 'humanoid robot on Mars' entails versus simpler robotic missions. There is no credible pathway to landing a humanoid robot on Mars within this timeframe. I deviate strongly from the market price because the evidence is overwhelmingly one-directional and the market volume is low (167/day), suggesting thin, potentially uninformed trading.

The Kalshi market prices this at 36%, but I believe this is significantly overpriced given the evidence. The key ambiguity is what 'nuclear fusion is achieved' means - if it means commercial fusion power, this is essentially impossible before 2030. If it means net energy gain (Q>1), NIF already achieved this in December 2022, which could mean this already resolves Yes. If it means sustained, repeatable net energy gain or grid-connected fusion power, all expert sources consistently say this is many years away. Every research article points in the NO direction - massive investment is flowing but no one has demonstrated commercial viability, and construction of first-of-kind reactors is just beginning. The 36% market price likely reflects ambiguity in resolution criteria and retail optimism about fusion hype. Given that commercial fusion before 2030 is near-impossible, and scientific milestones like NIF's ignition have already occurred without apparent resolution, I estimate ~12% probability, accounting for the small chance the question resolves on a less stringent criterion or an unexpected breakthrough at facilities like ITER, Commonwealth Fusion Systems' SPARC, or similar projects.

The Kalshi market prices this at ~20%, but I believe this is significantly overpriced given the resolution criteria. The question requires not just landing humans on Mars, but a *self-sufficient* colony of 10+ people residing there for a full Earth year before 2050. Consider the chain of prerequisites: Starship must become operational (still in testing with recent failures), orbital refueling must be demonstrated, uncrewed Mars missions must succeed, crewed Mars landing must occur, and then a self-sufficient colony must be established and sustained for a year. NASA considers even a crewed Mars *visit* by 2040 'audacious,' and their current plan involves building a moon base first as a stepping stone. Even the related market for Elon visiting Mars in his lifetime is only 9%. The 29% market for a human landing on Mars before 2050 (not colonizing—just landing) further contextualizes how ambitious the colonization requirement is. A self-sufficient colony of 10 people sustained for a year is orders of magnitude harder than a brief crewed visit. Every piece of evidence—Starship failures, NASA timelines, political instability—points strongly against resolution by 2050. The Kalshi market at 20% likely reflects thin volume (108/day) and speculative enthusiasm rather than calibrated assessment.

The Kalshi market prices this at 15%, which serves as my anchor. Creating a new personal income tax bracket specifically for NYC residents with incomes over $1 billion faces enormous hurdles: NYC cannot unilaterally impose income taxes without New York State legislative authorization, the state legislature would need to pass enabling legislation, and a billionaire income tax bracket would affect an extremely small number of residents (likely single digits) making it politically symbolic but practically challenging. While there's a broader blue-state trend toward taxing the wealthy, no specific NYC legislation targeting $1B+ incomes appears to be advancing. The 7-day price uptick of +5% suggests some renewed interest but from a very low base. Given the legislative complexity (state authorization required), the narrow target population, and the lack of any concrete bill progressing, I shade slightly below the market at 12%. The contrarian case would require rapid state legislative action plus NYC council passage, which seems unlikely in the remaining ~6 months.

The Kalshi market prices Thapar at 14% with a declining trend (-4% over 7 days, -2% over 30 days). The key drivers are: (1) a vacancy must open — Thomas resignation is priced at 47%, and Alito is another possibility, so there's roughly a 50-60% chance of at least one vacancy; (2) conditional on a vacancy, Thapar must be nominated — he's one of several candidates on Trump's shortlist but not the frontrunner; (3) conditional on nomination, Senate confirmation is very likely given Republican majority. The research confirms no vacancy has opened as of March 2026, and the declining price trend suggests the market is slightly cooling on Thapar. I see no strong reason to deviate significantly from the market price, so I estimate 13%, slightly below the current 14% given the negative momentum.

The Kalshi market prices this at 11%, but I believe even that is too generous. The question requires NO budget deficit in ANY of fiscal years 2025-2028. The FY2025 deficit is already locked in (the fiscal year started Oct 2024 and ends Sep 2025), and was projected at ~$1.8-2 trillion before Trump took office. The related market shows only 6% probability of the deficit-to-GDP ratio even falling below 5% for FY2026, meaning the market expects deficits well above $1 trillion annually. Research evidence shows government shutdowns, massive disruption, and no indication of deficit reduction — in fact, Trump's tax cut extensions would increase deficits further. Historically, the US hasn't had a budget surplus since 2001, and structural deficits from entitlements, defense, and interest payments make elimination virtually impossible without enormous tax increases or spending cuts far beyond what DOGE has achieved. The 11% Kalshi price likely reflects thin volume (144 contracts/day) and speculative positioning rather than genuine probability assessment. I anchor well below the market at 2%.

The Kalshi market prices this at 42% with a strong upward trend (+28% over 30 days). However, the evidence consistently shows significant obstacles: (1) Mamdani cannot raise corporate taxes unilaterally—he needs Albany's approval; (2) Governor Hochul has explicitly opposed tax hikes, especially ahead of her reelection; (3) As of mid-March 2026, no corporate tax legislation had been enacted or appeared close to passing, with the administration exploring alternative revenue sources like parking fees and property taxes. The NY State legislative session typically runs January-June, leaving limited remaining windows before the Jan 1, 2027 deadline. While there's a broader blue-state trend toward taxing corporations and Mamdani is clearly pushing hard, the gubernatorial veto threat is a major barrier. The market's recent price surge may reflect optimism about Mamdani's rhetoric rather than concrete legislative progress. I shade slightly below market at 35%, reflecting that the structural political obstacles (Hochul opposition, need for state approval) make passage before 2027 less likely than the current market implies.

The Kalshi market prices Chavez-DeRemer at 61% to be the next Cabinet departure after March 10, 2026, with a strong upward trend (+12% over 7 days, +36% over 30 days) and decent volume (~12,473 contracts/day), suggesting this is a well-traded and increasingly confident market. The research evidence shows no specific news about Chavez-DeRemer being under imminent pressure — she appears to still be in her role as Labor Secretary, and the most recent Cabinet departure (Noem) occurred before the March 10 cutoff. The Iran war is creating political pressure but seems directed more at national security officials than domestic Cabinet members. The absence of specific negative news about Chavez-DeRemer makes the 61% market price seem slightly high, but the strong upward trend suggests traders may have information or analysis not fully captured in these articles. I shade slightly below the market at 58%, respecting the trend while noting the lack of corroborating evidence in available reporting. The long time horizon to January 2029 means many Cabinet departures will happen, and the question is specifically about who is NEXT, making this inherently uncertain.

The Kalshi market prices this at 20% with a clear downward trend (-4% over 7 days, -15% over 30 days), suggesting declining confidence. The research shows no Airtable-specific IPO signals whatsoever — none of the articles mention Airtable directly as an IPO candidate. While the broader IPO market has been strong (Dow 50K, successful IPOs in 2025), there are also headwinds like government shutdowns creating uncertainty. Airtable, last valued around $11B in 2021, has not been mentioned in any IPO pipeline discussions, and there's no reporting of S-1 filings, banker selections, or management commentary about going public. With ~2 years remaining until the deadline, the base rate for any specific unicorn announcing an IPO in a given 2-year window is relatively low without concrete signals. I slightly shade below the market price at 18% given the persistent downward trend and complete absence of Airtable-specific IPO indicators.

The Kalshi market prices this at 66%, which is my primary anchor. However, several factors push me slightly below market price. The research evidence consistently points toward spending cuts (DOGE), government shutdowns, and fiscal austerity under Trump rather than large spending increases. The related markets show only 8-9% chance of $250B in cuts, suggesting spending hasn't actually been cut much despite rhetoric - but the question asks for a $400B *increase* above Q4 2025 levels in a single quarter, which is a very high bar. Federal spending can be lumpy (e.g., large quarterly variations from timing of payments, tax refunds, defense spending surges), and the mention of potential defense supplemental funding related to Iran tensions could contribute. The 7-day price decline of 5% suggests the market is moving toward lower probability, consistent with the austerity-focused news. I shade slightly below market at 0.62, reflecting the strong evidence of fiscal constraint but acknowledging that federal spending patterns often show large quarterly swings that could mechanically hit this threshold regardless of policy intent.

The Kalshi market prices exactly 0 rate changes before 2027 at 30%. The current fed funds rate is 3.5%-3.75% after two consecutive holds in Jan and March 2026. The Fed still projects one cut in 2026, with remaining FOMC meetings in April/May, June, July, September, October, and December 2026. Key factors: (1) The Fed has held steady twice but officials still pencil in one cut, and there were dissents favoring cuts at both meetings. (2) The Iran war/oil crisis and economic uncertainty are creating caution, but Powell suggested effects may be temporary. (3) Political pressure from Trump for lower rates persists. (4) Warsh nomination as new chair (potentially more dovish than his historical record) could shift dynamics once confirmed. (5) Related markets show ~41% chance rates are above 3.25% after Jan 2027 meeting, implying roughly 59% chance of at least one cut from current 3.5%-3.75%. With 6+ FOMC meetings remaining in 2026, the base rate for at least one change is relatively high, though the +13% weekly move in this market suggests growing uncertainty about cuts materializing. I slightly shade below the market price at 28%, as the combination of dissents, projected cuts, and many remaining meetings makes zero changes somewhat less likely than the market implies.

The Kalshi market prices this at 8%, but I believe even that is too high. Kai Cenat is the most popular Twitch streamer, but his estimated net worth is in the range of $10-30 million. Going from ~$20M to $1B in under 5 years would require roughly 50x growth, which is essentially unprecedented for a content creator without founding a major company or having a massive equity event. Even the wealthiest YouTubers/streamers (MrBeast, etc.) have not reached billionaire status purely from content creation. The 7-day price drop of 10 percentage points suggests the market is correcting from speculative overpricing (likely driven by fans). The low volume (66 contracts/day) indicates this is a thinly traded, noisy market prone to retail speculation. I'm setting this at 4%, below the market price, because the fundamental economics of reaching $1B as a streamer/creator in <5 years are extremely unfavorable.

The Kalshi market price is 49%, but with only 1 data point and 41 contracts of daily volume, this is extremely thin and unreliable as a signal. The evidence strongly leans toward YES: (1) January 2026 layoffs were up 118% year-over-year, the highest January since 2009; (2) nonfarm payrolls fell by 92,000 in February 2026; (3) late 2025 saw massive corporate layoffs (Amazon 14,000-30,000, UPS 48,000) establishing an elevated baseline; (4) the labor market was described as weakening with hiring stalling and quits at 5-year lows entering 2026. The threshold of 5,497,000 represents the 2025 level, and with early 2026 data showing dramatically elevated layoff activity, the trajectory suggests 2026 will exceed 2025. The related tech layoffs market at 87% YES with high volume and strong upward trend (+16.4% over 30 days) corroborates a broader white-collar layoff surge. I deviate upward from the 49% market price due to the extremely low volume/liquidity and the weight of factual evidence showing accelerating layoffs in early 2026.

The Kalshi market prices this at 8%, which I find reasonable but slightly optimistic. Key considerations: (1) Musk was born in 1971 and will be 127 by 2099 - life expectancy alone makes personal Mars travel very unlikely even if the technology works. (2) SpaceX has shifted priorities to the Moon, with Musk himself acknowledging Mars is 20+ years away. (3) Starship is still far from operational for even lunar missions, let alone Mars. (4) Related markets show only ~26% chance of any human landing on Mars before 2050 and ~20% for colonization before 2050. For Musk personally to visit, he'd need to survive long enough AND the technology must work AND he must be healthy enough to make the journey. Even with radical life extension advances, the conjunction of all required events is quite low. The market at 8% may even be slightly high given the recent pivot to Moon priority and ongoing Starship delays. I shade slightly below market at 7%.

The Kalshi market prices this at 67%, and the evidence broadly supports Blue Origin having a plausible path to landing an uncrewed Blue Moon MK1 before SpaceX lands an uncrewed Starship on the moon. Key factors favoring YES: Blue Origin is pausing New Shepard to focus resources on lunar capabilities; SpaceX's Starship faces significant remaining technical hurdles (orbital refueling, lunar configuration) and NASA has openly questioned SpaceX's timeline; Blue Moon MK1 is a smaller, more conventional lander that may be simpler to develop and deploy than the massive Starship HLS. Key factors favoring NO: SpaceX has a much faster iteration cadence and deeper flight heritage with Starship testing; Blue Origin has historically been slower in execution than SpaceX; neither company has confirmed an uncrewed lunar landing demo timeline, and new spacecraft typically take 6-7 years to develop. The question also requires at least one of these events to happen before 2030, which adds uncertainty. I'm slightly below the market at 65% because while Blue Origin's simpler architecture gives it an edge in this specific race, SpaceX's execution speed and Musk's renewed lunar focus could close the gap, and there's meaningful probability neither lands before 2030.

The Kalshi market prices US at 74%, which I'll use as my anchor. The evidence strongly supports the US being the frontrunner: NASA has a $20 billion moon base plan, Artemis II is imminent (April 2026), and both SpaceX and Blue Origin are actively working on lunar landers with a target of 2028 for crewed landing. However, there are real risks: the Artemis program has been repeatedly delayed, Starship still faces technical challenges (orbital refueling never demonstrated), and the program was restructured adding an extra mission before landing. China targeting 2030 is the main competitor but would need to beat the US. The question is whether ANY US crewed mission launches to the Moon before Jan 1, 2031 - Artemis II (lunar flyby, launching ~April 2026) already counts as 'sending humans to the Moon' if the question includes orbital/flyby missions. If Artemis II launches successfully, the US resolves YES regardless of landing timeline. This makes 74% reasonable or even slightly conservative given Artemis II is weeks away. However, 'to the Moon' might require landing. Given the market has likely priced in Artemis II's near-term launch and the landing uncertainties, I stay close to market at 73%.

Trump has already nominated Kevin Warsh as the next Fed chair (announced January 30, 2026), explicitly bypassing Judy Shelton. None of the research articles mention Shelton as a candidate for the position. The Kalshi market prices this at 1.80%, which reflects the near-impossibility of Shelton being confirmed given Warsh is the nominee. The only scenario where Shelton could become chair would require Warsh's nomination to fail in the Senate AND Trump to then pivot to Shelton as a replacement—a very unlikely chain of events, especially given Shelton's controversial 2020 confirmation battle where she was rejected by the Senate. I align closely with the market at 2%, giving a tiny sliver of probability to unexpected scenarios like Warsh withdrawal.

The Kalshi market prices this at ~10.6%, but the evidence strongly suggests the bill is dead. It passed the House but faces an insurmountable 60-vote filibuster threshold in the Senate, with only 53 Republicans and unified Democratic opposition. Senate leaders explicitly acknowledged 'the votes aren't there' and the bill has 'no chance of passing.' There is no viable path to eliminate the filibuster for this bill, and Trump's addition of controversial provisions has made passage even harder. The only scenario for YES would be a dramatic change like filibuster elimination or some unprecedented bipartisan deal, both of which are extremely unlikely. States are already proceeding independently, suggesting even Republican leadership views federal passage as implausible. I shade slightly below the market at 6% because the factual evidence is overwhelmingly negative and the market may have some residual noise from the relatively high volume of speculative trading.

Capital One announced its acquisition of Brex for $5.15 billion in January 2026, which would make Brex a subsidiary rather than an independent public company, effectively eliminating any realistic path to a Brex IPO. The Kalshi market currently prices Brex at 7%, which already reflects this acquisition news. However, there's a small residual probability that the deal could fall through due to regulatory issues or other complications, in which case Brex might eventually IPO. Even if the deal fell through, Ramp would still likely IPO first given Brex's diminished valuation and strategic uncertainty. The market price of 7% seems slightly high given the strong evidence that Brex is being acquired; I shade slightly below at 4% to account for the near-certainty that this acquisition closes and the low probability Brex would IPO first even if it didn't.

The Kalshi market prices Anthropic IPO-ing first at 63%, but the evidence strongly contradicts this. OpenAI has shared an IPO-like prospectus with investors (March 2026), is actively preparing for a public debut 'as soon as this year,' has $13.1B in revenue, and a $730B valuation. Meanwhile, Anthropic faces a Pentagon ban, supply chain risk designation, and significant government disputes that would delay any IPO plans. The related market shows 59% probability OpenAI announces an IPO before Jan 2027, further confirming OpenAI is much closer. Anthropic has no reported IPO plans or timeline. The 63% Kalshi price for Anthropic seems anomalous given this overwhelming evidence favoring OpenAI going first - the +22% 7-day swing suggests possible speculative momentum or thin market dynamics. I deviate significantly from the market price because every factual data point points to OpenAI being far more IPO-ready, with Anthropic facing major headwinds that make near-term IPO unlikely.

The Kalshi market prices this at 33%, which I use as my primary anchor. The question requires two consecutive quarters of negative GDP growth in 2025 or 2026. Key evidence: Q4 2025 GDP was positive (1.4%), so no negative quarters occurred in 2025. For 2026, the Iran war oil shock (March 2026) significantly elevated recession risk, with Moody's at 48.6% and Goldman at 30% for a recession within 12 months. However, those are probabilities of NBER-defined recession, not necessarily two consecutive negative GDP quarters (a stricter technical definition). The economy entered 2026 with some momentum despite headwinds, and even with the oil shock, two consecutive negative quarters would need to materialize by Q3-Q4 2026 at latest. The oil shock is genuinely concerning and represents a material risk not fully priced in earlier, but multiple analysts noted underlying economic resilience. I nudge slightly above the Kalshi price to 35%, reflecting the Iran war escalation risk that may not be fully digested, while acknowledging that two consecutive negative quarters is a high bar that requires sustained contraction.

The Kalshi market prices this at 87.2% with a strong upward trend (+16.4% over 30 days) and very high volume (~419K daily contracts), indicating a well-established and liquid market. The evidence strongly supports the YES direction: January 2026 alone saw 108,435 total job cuts (highest January since 2009) with tech as the second-largest sector. AI-driven layoffs are accelerating, with companies like Amazon (16,000 cuts), Meta (potentially 15,800+ cuts representing 20% of workforce), and others aggressively restructuring. The threshold is 447,000 information sector layoffs in 2026. Given that BLS 'information sector' data showed already elevated layoff levels in early 2026, AI-driven displacement is intensifying, recession fears are mounting, and investor rotation away from tech is pressuring companies to cut costs, the trajectory strongly favors exceeding the threshold. The market price appears well-calibrated; I see no strong reason to deviate significantly from it, settling at 0.88.

The market prices this at ~47.6%, but I believe this is significantly too high given the conjunction requirement. The related market for D-House + D-Senate (balance of power) is at 47.2%, but that only requires Democrats to win majorities (218+ House seats), not 235+ seats. Getting 235+ seats is a substantially higher bar—Democrats need a net gain of ~20 seats, not just 3. While the opposing party historically gains seats in midterms, gaining 20+ House seats is a much rarer event (comparable to 2018's wave). Meanwhile, the Senate map is very challenging: Democrats need to flip 4 seats from a 47-53 deficit, with limited targets in favorable territory. The conjunction of BOTH a large House wave (235+) AND flipping the Senate makes this quite unlikely. The research consistently highlights structural obstacles: aggressive Republican redistricting, mail-ballot restrictions, a difficult Senate map, and Republican fundraising advantages. While Trump's low approval provides a Democratic tailwind, most analysts suggest Democrats can retake the House majority but achieving 235+ seats requires a much larger wave. I estimate P(House 235+) ≈ 25-30% and P(Senate 51+) ≈ 30-35%, with strong positive correlation (both driven by national environment), giving a joint probability around 15-20%.

The Kalshi market prices this at 90%, but the evidence overwhelmingly supports a higher probability. Multiple factual sources from early 2026 confirm that over 300,000 federal employees left the payroll in 2025 alone, with the net workforce shrinking by ~242,000 between inauguration day and December 2025. The 50,000 threshold has been exceeded many times over. The question asks about cuts relative to December 2025 employee count before January 2027, and even with the administration ramping up some new hiring in early 2026, the massive reductions already documented (350,000+ departures, 242,000 net reduction) make it virtually certain this threshold is met. The only risk would be if the resolution criteria are interpreted very narrowly or if there's a massive rehiring wave that somehow nets below 50,000 reduction from the December 2025 baseline, but the evidence shows ongoing cuts into 2026 (FEMA, etc.) making this implausible. I price this higher than the market's 90% because the factual evidence from the resolution period is unambiguous.

The Kalshi market prices this at 30%, but the evidence overwhelmingly points to NO. The U.S. and Iran entered active military conflict starting ~February 28, 2026, with the killing of Khamenei, ongoing bombing campaigns, Iran blockading the Strait of Hormuz, and weeks of intensifying warfare. Even before the war, Iran was under heavy Western and UN sanctions making legitimate trade minimal. Historical U.S. imports from Iran have been negligible under sanctions regimes (typically well under $5M annually in recent years). With an active shooting war, any remaining trade channels would be completely severed. The only scenario for YES would be if the war ends quickly and some unusual post-war arrangement permits imports, or if there were pre-war imports in January-February before hostilities began that happened to exceed $5M — but given pre-existing sanctions, this is extremely unlikely. I deviate significantly below the 30% market price because the factual evidence of active warfare is overwhelming and decisive, and the market may not have fully adjusted to these developments (the price has been declining, dropping 5% in the last week).

The Kalshi market prices this at 15%, but I believe that significantly overstates the probability. A >25bps rate hike at a single meeting would be extraordinary - historically, the Fed has only done hikes of >25bps during aggressive tightening cycles (e.g., 2022). All available evidence points firmly away from hikes: the Fed cut rates three times in 2025, is oriented toward holds or further cuts, Trump is pushing for lower rates, the incoming Fed chair Warsh is hawkish but not advocating hikes, and inflation at 2.7% is elevated but not spiraling. For a >25bps hike in January 2028, we would need a dramatic inflation shock or economic regime change that is not currently foreseeable. The 15% market price likely reflects low liquidity (71 contracts/day average), a wide historical price range (2%-44%), and the inherent noise in far-dated, low-volume contracts. The related markets showing rates above 3.25-3.50% after early 2027 meetings at ~50% suggest modest rate levels, not a hiking cycle. I place this at 4%, reflecting the small but nonzero tail risk of an unforeseen inflationary scenario over the next ~2 years.

The Kalshi market prices this at 13%, but I believe that significantly overstates the probability. The Supreme Court just declined to hear the Kim Davis challenge to Obergefell in November 2025 with no comment from any justice — meaning fewer than 4 justices even wanted to take the case. This is the strongest possible signal that the current court has no appetite to revisit marriage equality. For this to resolve Yes by Jan 2029, the court would need: (1) a new case with standing to reach them, (2) at least 4 justices to grant cert, and (3) a majority to overturn — all within ~3 years. With ~70% public support, hundreds of thousands of existing same-sex marriages creating massive reliance interests, the Respect for Marriage Act providing federal statutory protections, and the court's recent demonstrated unwillingness to even hear such a case, this is extremely unlikely. Even if Thomas retires and is replaced by a more conservative justice, the court just showed it lacks the votes. The 13% market price likely reflects retail speculation and fear rather than careful legal analysis. I set this at 3%, reflecting the small residual possibility of an unexpected legal pathway or dramatic court composition change.

The Kalshi market prices this at 46%, but the evidence strongly points downward. The key development is that Trump has decoupled US-Saudi defense/economic deals from Israel normalization, removing the primary US leverage to push Saudi Arabia toward normalization. MBS explicitly stated he requires a 'path to a Palestinian state' which 'may take many years,' while Netanyahu has repeatedly rejected Palestinian statehood. The 7-day price drop of 8% and 30-day drop of 6% reflect the market digesting this reality. Additionally, by early 2026, US-Israel focus shifted to Iran military operations rather than normalization diplomacy. With no leverage mechanism forcing either side to compromise on the Palestinian state issue, no active negotiations reported, and ~3 years remaining, I assess the probability meaningfully below the current market price. The market at 46% may still reflect earlier optimism that hasn't fully corrected. I deviate downward to 30%, reflecting that while there's still time for circumstances to change (new Israeli PM, regional realignment post-Iran conflict), the structural obstacles are severe and the key incentive framework has been dismantled.

The Kalshi market prices this at 35%, but I believe the market is significantly overpriced. All factual evidence from 2025-2026 shows the U.S. strategy is focused on removing Chinese influence from canal-adjacent port operations through diplomatic and legal pressure — not on taking direct control of any part of the canal itself. Panama's Supreme Court voided CK Hutchison's port concession (a Trump diplomatic victory), but the canal remains fully under Panamanian administration with no indication of any U.S. seizure plans. The question requires the U.S. government to have 'taken control of at least some part of the Panama Canal' — an extraordinarily aggressive act that would violate the 1977 Carter-Torrens Treaty, constitute an act of aggression against a sovereign nation, face massive international backlash, and likely lack Congressional support. Even with Trump's aggressive rhetoric, there is zero evidence of concrete steps toward seizure — no military deployments, no ultimatums, no Congressional authorization. The base rate for the U.S. seizing sovereign infrastructure from treaty allies is essentially zero. The Kalshi price likely reflects rhetorical bluster and speculative risk premium rather than genuine probability of seizure. I deviate substantially from the market price because the evidence uniformly points away from resolution, and 'taking control' is a very high bar that diplomatic maneuvering over port concessions does not meet.

The Kalshi market prices this at 21%, but I believe this overestimates the probability. The key constraint is that formal elimination of the Department of Education requires congressional legislation with 60 Senate votes, which all reporting consistently confirms is unavailable. The Trump administration has aggressively pursued administrative dismantling — hollowing out staff, transferring functions to other agencies via interagency agreements, vacating the headquarters — but these actions do not constitute 'elimination' or 'sunsetting' of the department. The department still legally exists with residual staff. Even with Republican congressional deference to Trump, the filibuster threshold remains a hard barrier, and there's no indication of sufficient Democratic support or willingness to use reconciliation (which likely can't be used for this purpose). The administration itself frames this as 'returning education to the states' rather than shutting down, acknowledging the political impossibility of formal elimination. With ~3 years remaining until the deadline, some scenario involving filibuster elimination or a dramatic political shift is conceivable but highly unlikely. I deviate significantly below the market price because the market may be conflating administrative dismantling with formal elimination.

The market currently prices this at 34%, but I believe this significantly overestimates the probability. The evidence overwhelmingly points against a free trade agreement with China becoming law before January 2029. Key factors: (1) The October 2025 APEC deal was merely a partial tariff reduction framework, leaving average tariffs at ~47% - nowhere near 'free trade'; (2) Trump himself describes the relationship in terms of maintained high tariffs and leverage, not liberalization; (3) The Supreme Court struck down IEEPA tariff authority in early 2026, creating legal chaos that makes new comprehensive agreements harder; (4) The broader geopolitical context (nuclear testing, Taiwan tensions, strategic competition) is fundamentally incompatible with a free trade agreement; (5) A free trade agreement would need to pass Congress as law, which is an enormous additional hurdle even if negotiated. Historically, the U.S. has never had a free trade agreement with China, and the current trajectory is toward managed tariff competition, not liberalization. The 34% market price likely reflects confusion about what constitutes a 'free trade agreement' versus partial trade deals or tariff reductions. The general FTA market at 49% (any country) further suggests the China-specific probability should be much lower. I deviate substantially from the market price because every piece of evidence directionally points to NO.

The Kalshi market prices the purchase at 25%, but the related 'No Acquisition' market at 80% and the evidence strongly suggest this is overpriced for an actual *purchase*. The distinction matters: 'take control' is priced at 37%, which includes non-purchase scenarios (military bases, leases, etc.), while actual purchase faces enormous obstacles. Every piece of evidence points NO: Greenland's PM insists on sovereignty, the Vance-Denmark meeting ended in 'fundamental disagreement,' a broad European coalition opposes it, Greenland's population strongly resists, and even Trump advisers prefer an 'Art of the Deal' arrangement short of actual purchase. The 80% 'No Acquisition' price on the related market is more informative here — it implies only ~20% chance of any acquisition at any price, and this question specifically requires a *purchase from Denmark*. Historical base rate: the U.S. has never successfully purchased inhabited sovereign territory from a Western ally in modern history. The most likely outcome is some security/mineral partnership deal that falls short of actual territorial purchase. I deviate significantly below the 25% headline market price because the related market data and overwhelming evidence consensus point to ~5-10% probability of an actual purchase.

The Kalshi market prices this at 21%, but I believe this significantly overstates the probability. Historical base rate: no president has ever been impeached AND removed by the Senate. Trump was impeached twice before without conviction. The structural barriers are enormous: impeachment requires House majority (Democrats may win in 2026 but aren't eager to impeach), and Senate conviction requires 67 votes - meaning ~15-17 Republican senators would need to vote to convict, which is nearly inconceivable given the evidence shows Republicans consistently deferring to Trump. The research confirms: Democrats aren't prioritizing impeachment, Republican loyalty remains ironclad, and no clear impeachable offense has emerged that could fracture the GOP coalition. Even if Democrats win the House in 2026 and impeach, Senate conviction before January 2029 is essentially impossible absent an extraordinary scandal that turns Republicans against Trump. The 21% Kalshi price likely reflects speculative trading and possibly conflation with other removal scenarios (resignation, 25th Amendment), but this question specifically requires impeachment AND Senate conviction. I deviate sharply from the market price because the constitutional mechanics make this outcome extraordinarily unlikely.

The Kalshi market prices this at 12%, but I believe this is significantly overpriced. The acquisition of any part of Canada by the United States would be an unprecedented event in modern history - no sovereign democratic nation has been partially acquired by another through peaceful or coercive means in the post-WWII era. Canada is a G7 nation, NATO ally, and nuclear-umbrella partner with strong institutions and overwhelming public opposition to joining the US. Even Trump's rhetoric about making Canada the '51st state' was widely seen as posturing/trolling rather than actionable policy. The research articles show no concrete steps toward acquisition - Trump interviews don't even mention it. The Alberta secession market at 24% is interesting but even if Alberta voted to secede (unlikely), the path from secession referendum → actual secession → joining the US involves years of constitutional and legal processes that couldn't complete before Jan 2029. The Kalshi price likely reflects speculative trading and novelty interest rather than genuine probability assessment. I deviate substantially downward from the 12% market price because this would require an event with essentially no historical precedent.

The Kalshi market prices show significant divergence: the 'acquire any part' market is at 37%, while the 'No Acquisition' price market is at 80% (implying only 20% chance of acquisition), and the 'buy' market is at 25%. I weight the evidence heavily toward NO: every article from January 2026 shows Denmark, Greenland, and European allies firmly opposing any transfer of sovereignty; high-level meetings ended in 'fundamental disagreement'; even Trump advisers are wary of actual acquisition; and the 'framework of a future deal' appears to be about Arctic security cooperation rather than territorial transfer. The 37% Kalshi price seems inflated—likely driven by retail speculation around Trump's rhetoric rather than realistic assessment. International law, NATO alliance considerations, Greenlandic self-determination, and the lack of any actual negotiation framework for territory transfer all point strongly against acquisition before January 2029. The related 'No Acquisition' market at 80% and 'buy' market at 25% are more credible signals. I estimate the true probability at roughly 8%, reflecting the small but non-zero chance of some creative arrangement (e.g., a long-term lease or economic zone agreement that could be interpreted as partial acquisition).

The Kalshi market prices this at 19%, but I believe this is too high. Historical base rate: only one president (Nixon) has ever resigned, and he faced near-certain removal via impeachment. Every piece of evidence from the research shows Trump actively engaged in governing, pursuing an aggressive agenda, delivering State of the Union addresses, and actively campaigning to maintain Republican congressional majorities to prevent impeachment. There are no health crises, no imminent removal proceedings, and no signals whatsoever of resignation intent. The 19% Kalshi price likely reflects some combination of health risk (Trump is 78-82 during this term), potential deal-making scenarios (e.g., resigning to let Vance pardon him), and general uncertainty over a long time horizon. However, Trump has historically shown extreme resistance to leaving office (see January 6th) and is psychologically unlikely to voluntarily resign. Even facing two impeachments in his first term, he never considered resignation. I deviate substantially downward from the market price because the evidence uniformly points to NO, Trump's personality makes voluntary resignation extremely unlikely, and the market may be inflated by retail speculation on a low-volume contract (~473/day).

The Kalshi market prices this at 14%, but the overwhelming evidence points to an even lower probability. Manufacturing's share of GDP has been in secular decline for decades - it was around 11% in recent years, and reaching 13.1% (Q1 2005 levels) would require an unprecedented reversal. Every piece of evidence shows manufacturing is deteriorating under Trump's tariff policies: 100,000+ jobs lost, the Supreme Court struck down emergency tariffs, China is circumventing tariffs through trade diversion, and even 'success stories' barely register in GDP. Building new factories takes years, and we'd need roughly a 20% increase in manufacturing's GDP share in ~3 years - something that hasn't happened in modern US economic history. The structural forces against this (automation, services-dominated economy, high costs, lack of skilled workers) are immense. I shade below the market price of 14% because the evidence is uniformly negative, and the 14% likely reflects some speculative/thin-market noise (only 142 contracts/day average). Even accounting for the contrarian scenario where massive reshoring investments materialize and services sectors shrink relatively, reaching 13.1% by Q4 2028 is extremely unlikely.

The Kalshi market shows 73% probability, but I believe this significantly overestimates the likelihood. EU accession is an extraordinarily lengthy process - no country has joined since Croatia in 2013. The current candidates (Ukraine, Moldova, Western Balkans nations like Montenegro, Serbia, North Macedonia, Albania, Bosnia) all face major hurdles. Even Montenegro, the most advanced candidate, has significant rule-of-law issues and hasn't closed most negotiating chapters. Ukraine and Moldova only received candidate status in 2022 and are years away from completing negotiations. The accession process typically takes a decade or more, requires unanimous approval from all existing members, and involves closing 35 negotiating chapters. With less than 5 years until January 2030, and no candidate close to completing negotiations, the probability of any country joining is very low. The Kalshi market likely reflects wishful thinking or confusion about the timeline rather than realistic assessment of the accession process. Historical base rates and the current state of negotiations strongly suggest this is unlikely by 2030. I deviate substantially from the market price because the structural barriers to EU accession within this timeframe are well-documented and severe.

The Kalshi market prices this at 32%, but I believe this is significantly overpriced given the evidence. The most critical piece of information is Musk's February 2026 announcement that SpaceX is pivoting to lunar priorities and pushing Mars city-building out 5-7 years, explicitly abandoning a previously planned uncrewed Mars landing in late 2026. Starship is still in testing (11 test flights as of late 2025, with 6 failures in the first 10), orbital refueling remains undemonstrated, and NASA experts note new spacecraft typically take 6-7 years to develop. Mars launch windows occur roughly every 26 months — the remaining windows before 2030 would be approximately mid-2026 and late 2028. The 2026 window is essentially impossible given the pivot announcement and vehicle readiness. The 2028 window would require SpaceX to reverse its stated priorities, complete Starship V3 development, demonstrate orbital refueling, and prepare an interplanetary mission — all within ~2.5 years. Historical base rates for ambitious space timelines suggest massive delays are the norm. I deviate substantially from the 32% market price because the February 2026 pivot announcement appears to be strong disconfirming evidence that may not be fully reflected in a relatively low-volume market (~273 contracts/day).

The Kalshi market prices this at 48%, but I believe this is significantly overpriced. The question requires a humanoid robot to walk on Mars before 2035, which demands: (1) a rocket capable of landing on Mars with a humanoid robot payload, (2) a humanoid robot capable of walking on Mars's surface, and (3) someone actually planning and executing such a mission. All evidence points strongly against this. SpaceX has shifted priorities to the Moon, Starship hasn't demonstrated orbital refueling, no space agency or company has announced plans to send a humanoid robot to Mars, and current humanoid robots are focused entirely on Earth-based factory/commercial applications. Even uncrewed Mars landers take years to develop, and no humanoid robot has ever operated in space. The related Kalshi markets show humans landing on Mars before 2050 at only 26%, and Mars colonization before 2050 at ~20%. A humanoid robot walking on Mars before 2035 would require capabilities beyond what any current program is developing on a much shorter timeline. The 48% market price likely reflects speculative retail trading with relatively low volume (193/day), not informed probability assessment. I deviate sharply downward to ~5%.

The Kalshi market price is 34.2%, but I believe this is significantly overpriced due to ambiguity in what 'nuclear fusion is achieved' means. If it means net energy gain (Q>1), NIF already achieved this in December 2022 with ignition. If the market hasn't already resolved based on that, it likely requires something more - such as a commercially viable fusion power plant or sustained net energy production connected to a grid. All research summaries unanimously point to commercial fusion being at least a decade away. SPARC (Commonwealth Fusion Systems) is still being built and won't demonstrate net energy before 2030 in a commercial sense. ITER is massively delayed. No private company is close to a grid-connected fusion plant. The 30-day price drop of -12.8% suggests the market is correcting downward as reality sets in. The relatively low volume (236 contracts/day) suggests the price may not be well-calibrated. Given that every expert source says practical fusion is roughly a decade away, and the only plausible 'achievement' (NIF-style ignition) has arguably already happened without resolving this market, I estimate roughly 12% probability.

The Kalshi market prices this at ~20%, but I believe this significantly overestimates the probability. The resolution criteria require a 'self-sufficient colony of at least 10 people residing on Mars for at least one Earth year' before 2050. This is extraordinarily demanding: it requires not just landing humans on Mars, but sustaining 10+ people self-sufficiently for a full year. As of late 2025, SpaceX Starship has failed on 6 of 10 test flights and hasn't demonstrated orbital refueling — a prerequisite for any Mars mission. Even optimistic timelines suggest first human landing no earlier than late 2030s. Building from first landing to a self-sufficient 10-person colony within the remaining years before 2050 is nearly implausible. The related market for Elon Musk merely visiting Mars in his lifetime is only 8%, and a human landing on Mars before 2050 (implied by the rail comparison market at 26%) is itself uncertain. A self-sufficient colony is orders of magnitude harder than a landing. Historical space program timelines consistently slip — Apollo took 8 years with massive national commitment, and Mars colonization faces far greater technical challenges (life support, radiation, food production, return capability). I deviate substantially below the market price because prediction markets on long-dated, exciting-sounding space questions tend to attract optimism bias from retail traders.

The Kalshi market prices the NDA submission before Nov 2026 at 48%, but with very low volume (6 contracts/day) and only 3 data points, suggesting this price is noisy and not well-established. The related market for FDA approval before Oct 2027 at 39% provides a useful consistency check — if NDA submission probability were truly 48%, approval by Oct 2027 would need to be conditional on a relatively fast review, which seems plausible but tight. Key concerns: (1) None of the research articles mention COMPASS Pathways being close to filing an NDA or having completed Phase 3 trials successfully; (2) The FDA's increasingly stringent regulatory environment (denying/discouraging multiple applications) creates headwinds; (3) COMPASS's Phase 3 program for COMP360 has faced challenges historically, including mixed Phase 2b results. As of mid-2025, COMPASS would need to have substantially completed their Phase 3 program and be ready to compile and submit the NDA within roughly a year — a tight timeline given no public evidence of imminent submission. I discount slightly from the thin market price to 40%, reflecting the absence of positive signals about trial completion and the challenging regulatory environment.

The national debt was already ~$36 trillion when Trump took office in January 2025. With annual deficits projected at $1.5-2+ trillion per year by the CBO, reaching $40 trillion by Q4 2028 is virtually certain — it would require only ~$4 trillion in additional debt over 4 years, well below projected deficit accumulation. The 'One Big Beautiful Bill' with its tax cuts would add further to deficits. The Kalshi market prices this at 99%, which accurately reflects the near-certainty of this outcome. There is no plausible scenario (massive surplus, debt restructuring) that would prevent crossing $40 trillion. I align with the market at 0.99.

The Kalshi market prices this at 46%, but I see strong reasons to adjust downward. The evidence is overwhelmingly negative: Trump has decoupled the Saudi defense/trade deals from normalization requirements, removing the primary US leverage to push Saudi Arabia toward recognizing Israel. MBS got F-35s and defense cooperation without any normalization commitment. Saudi Arabia's foreign policy focus is on intra-Gulf disputes (UAE/Yemen) and regional security, not Israel. Netanyahu faces elections and is focused on domestic survival, not making concessions on Palestinian statehood that Saudi Arabia would require. The US-Iran conflict adds further unpredictability. The market has been trending sharply downward (-8% in 7 days, -6% in 30 days), reflecting this deteriorating outlook. Historically, normalization deals require intense diplomatic pressure and mutual incentives—neither exists here now that Saudi Arabia has gotten what it wanted from the US independently. The 3.5-year window still provides some possibility of changed circumstances (new Israeli PM, regional realignment post-Iran conflict), but the structural obstacles are significant. I adjust below market to ~30%.

The Kalshi market prices this at 30%. All research evidence strongly supports the NO direction: as of March 2026 (over a year into the term), zero Supreme Court justices have been confirmed, no vacancies exist, and no retirements are imminent. The key related market shows Clarence Thomas resignation at only 48%, and even if Thomas retires, getting a second vacancy requires either another retirement or a death. Trump's hostility toward his own nominees (Gorsuch, Barrett) after the tariff ruling may actually discourage voluntary retirements. With roughly 3 years remaining in the term, there's still time for events to unfold, but needing 2 confirmations when 0 vacancies currently exist is a high bar. Historical base rate: only about half of 4-year presidential terms see 2+ SCOTUS confirmations. Given the current lack of any vacancy signals and that we're already 25%+ through the term, I'll shade slightly below the market at 28%.

The Kalshi market prices Rippling's IPO before June 1, 2026 at just 2%, having dropped sharply (-13% over 7 days, -19% over 30 days). This suggests the market has moved strongly against an imminent IPO. The related market shows Deel is favored 73% to IPO before Rippling, further suggesting Rippling is not rushing to go public. There is no news indicating Rippling has filed an S-1 or announced IPO plans. With roughly 11 months remaining until the deadline and no concrete IPO signals, I see no reason to deviate from the market's current 2% estimate.

The Kalshi market prices the Fed maintaining rates at the March 2027 meeting at 62%, which is my strongest anchor. The evidence supports this: as of March 2026, the Fed held rates at 3.5%-3.75% for two consecutive meetings, citing elevated uncertainty from the Iran war and oil crisis. Powell signaled the Fed is 'well positioned to wait,' and the December 2025 dot plot projected only one cut in 2026. The related market showing 30% probability of zero rate changes before 2027 (rising sharply +13% in 7 days) suggests growing expectations that the Fed may hold steady for an extended period. The 'above 3.25% after March 2027' market at 53% is consistent with limited cutting. However, there's meaningful probability (~38%) of a cut at the March 2027 meeting, reflecting that by then the Fed may have more clarity on inflation/growth dynamics and could resume easing. I see no strong reason to deviate from the market price, so I align closely at 0.61.

The market prices this at 15%, but I believe that significantly overstates the probability given the evidence. A >25bps hike at the January 2028 meeting would be extraordinary. As of early 2026, the Fed funds rate is ~3.5-3.75% after three consecutive cuts, with the policy debate entirely centered on cuts vs. holds—no officials are advocating hikes. Kevin Warsh, nominated as new Fed chair, has recently shifted toward favoring lower rates despite his hawkish history, and Trump continues pressuring for lower rates. For a >25bps hike to occur in January 2028, we'd need a dramatic inflation resurgence requiring emergency-style tightening—historically extremely rare (the Fed hasn't done >25bps hikes since the aggressive 2022-2023 cycle, and even then it took months of building consensus). The Kalshi price of 15% likely reflects thin trading (71 contracts/day) and the wide historical range (2-44%) suggests noise rather than informed pricing. The 30-day drop of 29 percentage points also suggests the market is correcting toward lower probability. I set my estimate at 4%, reflecting that while tail risks exist over a 2-year horizon, the institutional, political, and economic environment makes a >25bps hike nearly inconceivable.

The Kalshi market prices this at 91%, and the evidence strongly supports a high probability. The 2025 trade deficit was ~$901.5 billion in goods and services, and $170 billion is an extremely low threshold - the US hasn't had a trade deficit that small since the early 2000s. Monthly deficits alone are running ~$70 billion, meaning just 2.5 months of 2026 trade would exceed $170 billion. Even with aggressive tariffs (many of which have been struck down by the Supreme Court), economists agree that trade deficits are driven by macroeconomic fundamentals like fiscal deficits and savings rates, not tariffs. The federal deficit remains very large (93% chance it exceeds 5% of GDP per the related market). The 7-day price drop of 6% likely reflects noise given low volume (134 contracts/day). I'm pushing slightly above the market price to 95% because $170B is such a low bar relative to recent ~$900B annual deficits that virtually no plausible scenario gets the deficit below this threshold.

Current CO2 is at 430 ppm (June 2025 peak). The question asks whether CO2 reaches 440 ppm before January 2030. CO2 has been rising at roughly 2.5-3 ppm per year recently, and with record fossil fuel emissions projected for 2025 and no meaningful reduction trajectory, we'd expect ~442-445 ppm by the 2029 seasonal peak (May-June). However, the 430 ppm figure is the seasonal peak; the annual average is lower (~425-426 ppm). The question likely refers to peak readings since it says 'at least 440.' At ~2.5-3 ppm/year growth, reaching 440 by the May 2029 peak (the last seasonal maximum before Jan 2030) requires ~10 ppm increase from 430, meaning ~2.5 ppm/year over 4 years. This is tight but plausible given accelerating trends. The Kalshi market at 86% reflects this assessment. However, the 30-day decline of 9 percentage points suggests some participants may be reassessing the pace. I'm slightly below market at 82% because the math is tight — we need the seasonal peak to hit exactly 440 by May 2029, and while the trend supports it, any slight deceleration in the growth rate (e.g., back to 2.3 ppm/year) could leave us at 438-439 ppm, just short.

The Kalshi market prices this at 10%. Breaking this down: Musk (born 1971) would be 127 by 2099, so realistically he has perhaps 30-40 years of remaining life expectancy. The question requires not just humans landing on Mars, but Musk *personally* going. Related markets show only 30% chance of any human landing on Mars before 2050, and 16% for colonization before 2050. Musk has recently pivoted SpaceX priorities to the Moon first, pushing Mars timelines out 5-7+ years. Starship still hasn't achieved orbital refueling - a prerequisite for Mars missions. Even if crewed Mars missions happen in the 2040s-2060s timeframe, the probability that Musk personally goes (given his age, health risks of Mars travel, and the fact that early missions would likely send younger astronauts) is substantially lower than the probability of any human going. I'd estimate ~40-50% chance humans reach Mars by 2070, but only ~15-20% conditional probability that Musk personally goes given humans reach Mars in his lifetime. This yields roughly 6-10%. The market at 10% seems reasonable but perhaps slightly generous given the pivot away from Mars and Musk's aging. I'll shade slightly below market at 8%.

The Kalshi market prices this at 64%, which I'll use as my anchor. The evidence broadly supports Blue Origin having a plausible path to landing an uncrewed Blue Moon MK1 before SpaceX lands an uncrewed Starship on the moon. Key factors favoring YES: Blue Origin is redirecting all resources from New Shepard to Blue Moon development; NASA is openly considering sidelining SpaceX for Artemis III; SpaceX still hasn't demonstrated critical capabilities like in-orbit refueling needed for lunar missions. Key factors favoring NO: SpaceX has a much faster iteration cadence with 11+ Starship test flights already; Musk's pivot to moon priority could accelerate Starship lunar development; Blue Origin has historically been much slower in execution than SpaceX. Blue Moon MK1 is a smaller, simpler lander than Starship HLS, which could give it an advantage in reaching an uncrewed landing first, but Blue Origin hasn't yet demonstrated New Glenn reliability at scale. I'm slightly discounting from the market price to 62% because SpaceX's rapid iteration pace and Musk's stated lunar priority create meaningful risk that SpaceX could surge ahead despite current delays.

The Kalshi market prices US at 70% to be the next country to send humans to the Moon before Jan 1, 2031. The evidence supports this range: Artemis II (crewed lunar flyby) is launching April 2026, demonstrating real progress. However, the actual landing mission has been restructured - the landing (now Artemis IV) is targeted for 2028 but oversight officials doubt this timeline. Key risks include Starship development delays (needed for the lunar lander), the Orion heat shield issue, and the historical pattern of NASA timelines slipping. China targets 2030 but would need to beat the US. The restructuring adding an Earth-orbit docking test (Artemis III in 2027) before attempting the landing adds another potential delay point. I slightly shade below the market at 0.68 because the 2028 landing target has significant execution risk with Starship's orbital refueling still undemonstrated, and the deadline is end of 2030 - meaning even with delays there's some buffer, but multi-year slips are common in crewed spaceflight programs.

Trump nominated Kevin Warsh, not Judy Shelton, as Fed chair in January 2026. The question specifically asks whether Judy Shelton will be the 'first person confirmed' as Fed chair before 2029. Since Warsh is the nominee and Shelton was not selected, the only path to YES would require Warsh's confirmation to fail AND Trump to then pivot to Shelton as his next pick—a highly unlikely chain of events. The Kalshi market prices this at 1.7%, which already reflects this near-impossibility. Multiple research articles from late 2025 through March 2026 show zero mention of Shelton as a candidate. I align closely with the market at the minimum reasonable probability.

The Kalshi market prices this at 10.8%. All available evidence strongly points toward NO: the bill passed the House but faces an insurmountable filibuster in the Senate, with Democrats unified in opposition and Republicans lacking votes to change filibuster rules. Senate leadership (Thune) has explicitly confirmed they don't have the votes. Trump's additional demands (ending mail voting, transgender provisions) make bipartisan compromise even less likely. The only path would be a filibuster rule change, which multiple Republican senators have firmly rejected. The market at ~11% may slightly overstate the probability given how definitively this has been blocked; I shade slightly below market to ~8%, reflecting that there's essentially no viable legislative pathway with ~9 months remaining, and the political dynamics are unlikely to shift enough to break the filibuster impasse.

Capital One announced an acquisition of Brex for $5.15 billion in January 2026. If this deal closes, Brex will become a subsidiary of Capital One and will not pursue an independent IPO, meaning Ramp would IPO first (resolving No). The Kalshi market currently prices Brex at 7%, which already reflects this acquisition news. However, there's a small residual chance the deal falls through due to regulatory issues or other complications, in which case Brex could theoretically still IPO independently before Ramp. Given that Capital One is a major financial institution with regulatory expertise and the deal has been publicly confirmed by both sides, the probability of deal failure is low (perhaps 10-15%). Even if the deal fails, Brex would still need to IPO before Ramp, which is far from certain. I'll price this slightly below the market at 4%, as the acquisition appears very likely to close and eliminate Brex's IPO path entirely.

The Kalshi market prices Anthropic IPO-ing first at 66%, but the evidence strongly points in the opposite direction. OpenAI is actively preparing IPO-like prospectus documents, has a $730B valuation, Pentagon deals, and market consensus suggests it could IPO as soon as 2026 (50% chance before Jan 2027 per related market). Meanwhile, Anthropic faces severe headwinds: Trump administration banned federal use of its technology, Pentagon blacklisting, and ongoing legal battles that create massive business uncertainty — all unfavorable for near-term IPO planning. The +21% 7-day price swing on the Anthropic market with relatively low volume (364 contracts/day) suggests this may be noisy or driven by short-term sentiment rather than fundamentals. Given the overwhelming factual evidence that OpenAI is much further along the IPO path and Anthropic faces significant government-related obstacles, I deviate substantially from the market price downward to ~30% for Anthropic IPO-ing first.

The Kalshi market prices recession at 36%, which is my primary anchor. The market definition requires two consecutive quarters of negative GDP growth in 2025 or 2026 per BEA data. Key evidence: Q3 2025 GDP was +4.3% and Q4 2025 was +1.4% — both positive, so no recession has started yet. For resolution, we'd need two consecutive negative quarters in the remaining quarters of 2026 (Q1-Q4). The Iran war escalation (Goldman at 30% recession probability, EY at 40%) and weak consumer sentiment are genuine headwinds, but going from +1.4% growth to two consecutive negative quarters is a significant shift. The technical definition of two consecutive negative GDP quarters is historically quite rare and harder to achieve than a general 'recession' — even the NBER-defined 2001 recession didn't have two consecutive negative quarters. I shade slightly below the Kalshi price (which tracks NBER recession, a broader definition) to ~32%, reflecting that consecutive negative GDP quarters is a stricter criterion than what many recession probability estimates reference.

The Kalshi market prices this at 85.9%, which I'll use as my strong anchor. The evidence strongly supports the YES direction: January 2026 saw 108,435 job cuts (highest since 2009, up 118% YoY), with major tech companies like Amazon (16,000 cuts in Jan 2026 alone), Pinterest, and others driving layoffs. AI-driven workforce reduction is accelerating as a structural trend (55,000 AI-attributed layoffs in 2025, up 12x from two years prior). The threshold is 447,000 information sector layoffs in 2026. Given that January alone saw massive cuts and the trend appears to be accelerating due to AI adoption, economic uncertainty, and cascading effects from major tech companies, the pace seems consistent with exceeding this threshold. The 30-day price increase of +16.1% reflects the market incorporating the very strong January 2026 data. I see no strong contrarian evidence — there's no sign of a hiring rebound or policy intervention that would reverse the trend. I align closely with the market at 0.86.

The market prices this at 46%, but I believe this significantly overstates the probability of BOTH conditions being met simultaneously. The question requires Democrats to win 235+ House seats AND 51+ Senate seats. While Democrats are favored to retake the House, 235 seats represents a substantial majority (net gain of ~20 seats) — multiple articles emphasize the narrow battlefield makes a wave unlikely, with only 36 competitive races vs 49 in 2018. The Senate is even harder: Democrats need to net 4 seats from a 47-53 deficit, flipping seats mostly in Trump-won states. Cook Political Report says Republicans are still favored to hold the Senate. Even if we generously assign ~30% probability to Democrats winning 235+ House seats and ~25% to winning 51+ Senate seats, the correlation between these outcomes means the joint probability would be somewhere around 15-20% at most. However, I'm troubled by the market price at 46% with decent volume (1420/day) and 105 data points, suggesting this is well-traded. The 30-day trend is strongly upward (+6%). But the research evidence consistently points to structural barriers making this combo very difficult. The Texas special election swing is encouraging for Democrats but individual races don't guarantee wave-level outcomes across both chambers. I'm deviating substantially from the market price because the conjunction of two individually uncertain events should yield a much lower probability than the market implies, and the research strongly supports difficulty in achieving both thresholds.

The Kalshi market prices this at 90%, but the evidence overwhelmingly supports a higher probability. Multiple factual sources from early 2026 confirm that the federal workforce shrank by approximately 242,000-300,000+ employees between January 2025 and December 2025. The question asks whether more than 50,000 federal employees will be cut relative to the December 2025 count before January 2027 — meaning additional cuts beyond the already-reduced December 2025 baseline. Given that (1) additional FEMA cuts of 10,000+ positions were planned for 2026, (2) a new OPM rule effective March 2026 enables easier firings of ~50,000 reclassified positions, (3) the overall trend of workforce reduction continued through early 2026 with 300,000+ total reductions confirmed as of March 2026, and (4) the administration shows no signs of reversing course, exceeding 50,000 additional cuts from the December 2025 baseline by January 2027 is near-certain. The market at 90% likely reflects some residual uncertainty about measurement methodology or court interventions, but the sheer scale of ongoing cuts makes this threshold very likely to be met. I push above the market price to 0.97 given the strong factual evidence.

The Kalshi market prices this at ~34%, but the evidence overwhelmingly points to NO. The U.S. and Iran are in active military conflict since late February 2026, with Iran's supreme leader killed, its navy destroyed, and the Strait of Hormuz largely closed. Even before the war, U.S. imports from Iran were effectively near zero due to comprehensive sanctions. Historical U.S. Census data typically shows Iran imports well under $5M annually during sanctions periods. The war makes any normalization of trade in 2026 virtually impossible - even if a ceasefire occurs, reimposing trade flows takes months to years. The market at 34% seems significantly overpriced, possibly due to low volume (82 contracts/day) and speculative trading. The only scenario for YES would be a rapid peace deal followed by immediate sanctions relief, which contradicts all current evidence of ongoing hostilities and Trump's demand for unconditional surrender. I deviate sharply downward from the market price to ~5%.

The Kalshi market prices this at 13%, but the evidence strongly suggests this is too high. The Supreme Court explicitly declined to hear the Kim Davis challenge to Obergefell in November 2025 without comment, meaning fewer than 4 justices wanted to take it up. Only Justice Thomas has publicly called for reconsidering Obergefell. The Respect for Marriage Act (2022) provides additional legislative backstop. Public support for same-sex marriage is ~70%. For this to resolve YES by Jan 2029, the Court would need a new case to reach it, 4+ justices to grant cert, and 5+ to overturn — all within ~3 years, after just refusing the most prominent vehicle. The 13% market price likely reflects speculative risk-premium and low-information trading (average volume ~506/day). I deviate significantly downward because the November 2025 cert denial is a very strong signal that this Court will not revisit Obergefell, and no plausible pathway exists in the remaining timeframe.

The Kalshi market prices this at 31%, but I believe this significantly overestimates the probability. The evidence overwhelmingly points away from a U.S. takeover: (1) The U.S. strategy has focused on removing Chinese influence from canal ports through diplomatic/legal pressure on Panama, which has largely succeeded without requiring any U.S. control; (2) Panama is a functioning democracy and U.S. ally - seizing its sovereign infrastructure would be unprecedented in modern history and would devastate U.S. credibility throughout Latin America; (3) The U.S. military is heavily engaged in a major conflict with Iran, making a simultaneous military operation in Panama extremely unlikely; (4) Every factual article indicates the situation is resolving favorably for U.S. interests WITHOUT direct control - Panama's courts voided CK Hutchison's concession, Maersk is taking over operations, and canal traffic is increasing. The market at 31% likely reflects Trump's aggressive rhetoric and demonstrated willingness to use force (Venezuela/Maduro capture), but rhetoric ≠ action, and the diplomatic path is working. I deviate substantially from the market price because taking sovereign territory from an allied democracy has essentially no post-WWII precedent for the U.S., and the strategic objectives are being met through other means.

The Kalshi market prices this at 19%, but the evidence strongly suggests this should be lower. Every factual article consistently confirms that formal elimination of the Department of Education requires Congressional legislation needing 60 Senate votes, and there is no indication Democrats will provide those votes. The Trump administration has been aggressively hollowing out the department — cutting staff by half, transferring functions to other agencies, and vacating its headquarters — but these are administrative workarounds, not formal elimination. The market question requires the department to be 'sunsetted or eliminated entirely,' which means Congressional action. The 7-day and 30-day price trends are both declining (-5% and -3% respectively), indicating the market is moving toward NO. With roughly 2.5 years remaining until resolution but no viable legislative path, and the administration itself acknowledging it needs Congress to act, I estimate the probability significantly below the current market price at around 8%. The contrarian case would require Republicans gaining a filibuster-proof Senate majority or Democrats unexpectedly supporting elimination — both extremely unlikely scenarios.

The Kalshi market prices this at 35%, but I believe this is significantly mispriced given the evidence. A 'free trade agreement' with China that 'becomes law' is an extraordinarily high bar. The research evidence overwhelmingly points against this: (1) The deals being discussed are limited frameworks around specific issues like fentanyl and tariffs, not comprehensive free trade agreements; (2) Trump maintains 20-50% tariffs on Chinese goods and frames China as an adversary; (3) The Supreme Court struck down IEEPA tariff authority, creating additional legal complexity; (4) Trump threatened 100% tariffs on Canada for even considering a trade deal with China; (5) No historical precedent exists for a U.S.-China free trade agreement, and the political environment in both countries makes this nearly impossible. The market question specifically requires the agreement to 'become law,' meaning Congressional ratification - an almost inconceivable outcome given bipartisan anti-China sentiment. The Kalshi market for any FTA (43%) is also dropping sharply (-17% over 30 days). I suspect the market name may be misleading some traders who conflate limited tariff deals/frameworks with actual free trade agreements. The probability should be very low - perhaps 3-5%.

The Kalshi market prices this at 25%, but I believe this is significantly too high given the evidence. The question specifically requires a *purchase* of Greenland, which is the most restrictive form of acquisition. The related 'No Acquisition' market at 77% and the broader 'take control' market at 36% both suggest the purchase scenario is less likely than general control. Every piece of evidence points strongly against a purchase: Greenland's PM insists sovereignty red lines must be respected, Denmark and all major European allies have drawn firm lines, Greenland's population is culturally mobilized against it, and even Trump advisers prefer alternatives to full purchase. Trump's January 2026 'framework deal' appears to be a face-saving off-ramp focused on Arctic security cooperation rather than actual territorial purchase. The tariff threats were walked back. For a purchase to happen, Denmark's parliament would need to approve it, Greenland's government would need to consent, and a price would need to be agreed — all within ~3 years. There is no historical precedent for purchasing sovereign territory from a NATO ally against the wishes of its population. The 25% Kalshi price likely reflects speculative interest and the general unpredictability of Trump, but the specific mechanism of 'purchase' faces near-insurmountable legal and political barriers.

The Kalshi market prices this at 23%, but I believe this significantly overstates the probability. Impeachment AND removal requires: (1) a House majority voting to impeach, and (2) a two-thirds Senate supermajority (67 senators) voting to convict. Even if Democrats win the House in 2026 midterms and impeach Trump, they would need 67 Senate votes to convict. Democrats could at best win a slim Senate majority (51-53 seats), meaning they'd need 14-16 Republican senators to vote for conviction. Historically, no president has ever been removed via impeachment - Trump himself was impeached twice and acquitted both times. The evidence shows Republicans are acting as a 'rubber stamp' for Trump, Democrats aren't even prioritizing impeachment, and even Democratic leaders see it as impractical. The 67-vote Senate threshold is an enormous barrier that has never been overcome. The Kalshi price at 23% seems inflated, possibly driven by speculative trading or confusion about the difficulty of conviction vs. impeachment alone. Even accounting for tail risks (major scandal, economic crisis causing Republican defections), getting 67 senators is nearly unprecedented. I'm setting this at 4%, reflecting the extreme institutional barriers while acknowledging some small probability of an extraordinary scenario.

The Kalshi market prices this at 12%, but I believe this is significantly overpriced. The US acquiring any part of Canada would be an unprecedented event requiring either: (1) a negotiated territorial transfer, which Canada's government and population would never agree to, (2) military conquest, which would be an invasion of a NATO ally and is essentially unthinkable, or (3) secession of a Canadian province followed by US annexation, which would require years of legal/political processes. All research evidence shows Trump's rhetoric about Canada as the '51st state' remains purely rhetorical - the actual policy actions are tariffs and trade disputes, not territorial acquisition. Canada is actively diversifying away from the US and strengthening its sovereignty. The Alberta secession market at 15% is itself likely overpriced, and even if Alberta voted to secede, the path from a referendum to actual US acquisition within this timeframe is extraordinarily unlikely. Historical base rate for peaceful territorial transfers between developed democracies in modern times is essentially zero. I deviate substantially from the 12% market price because Kalshi political novelty markets frequently overprice extreme/attention-grabbing scenarios, and the volume (445/day) isn't high enough to suggest deep institutional conviction.

The Kalshi market for this specific question prices acquisition at 36%, while the related 'No Acquisition' price market is at 77% (implying ~23% chance of acquisition), and the 'Will Trump buy Greenland' market is at 25%. There's a notable discrepancy between the 36% main market and the related markets suggesting 23-25%. The evidence overwhelmingly points toward NO: the Vance meeting ended in 'fundamental disagreement,' Greenland's PM insists on sovereignty, a broad European coalition opposes it, Denmark has rejected every historical attempt, even Trump's own advisers are divided, and there's been no formal purchase offer. The 36% market price seems inflated relative to the related markets and the evidence. Historical base rate for territorial acquisitions by the US in the modern era is essentially zero. The timeline (by Jan 2029) gives about 3 more years, but sovereignty transfers of this magnitude typically require years of negotiation even when both parties are willing—here the seller is explicitly unwilling. I'm pricing this well below the main market at 12%, more aligned with the fundamental difficulty of this transaction and closer to but still below the related market signals.

The Kalshi market prices this at 25%, but I believe this is significantly overpriced. Historical base rate: only one president (Nixon) has ever resigned, and that was under extraordinary circumstances (bipartisan impeachment with near-certain conviction). All article evidence from early 2026 shows Trump actively governing, delivering State of the Union addresses, pursuing military operations, and engaging combatively with opponents — the opposite of someone considering resignation. Democrats aren't even pursuing impeachment, and Trump's behavior pattern across both terms shows he fights rather than concedes. The 25% market price likely reflects thin volume (473 contracts/day) and speculative retail interest rather than informed probability assessment. Even accounting for ~3 years remaining in the term and tail risks (health emergency at age 79-82, unforeseen crisis), the probability of voluntary resignation is very low. I'm setting this at 8%, which accounts for health/incapacitation scenarios that might force a resignation but reflects that the overwhelming evidence points to Trump serving his full term.

The Kalshi market prices this at 14%, but the evidence strongly suggests even that is too high. Manufacturing's share of US GDP has been in secular decline for decades - it was around 11% in recent years, and reaching 13.1% (the Q1 2005 level) would require an unprecedented reversal of ~2 percentage points in GDP share within ~3 years. The evidence uniformly points against this: 100,000+ manufacturing jobs lost since Trump took office, the Supreme Court struck down his emergency tariff authority, China is successfully evading tariffs through rerouting, and even manufacturing 'success stories' are niche, low-volume operations that barely register in GDP. Building factories takes years, and announced investments are non-binding. The structural forces (automation, lower overseas wages, services-dominated economy) are overwhelming. I deviate below the Kalshi price of 14% because the market likely has speculative/thin volume (142 contracts/day) and the evidence is overwhelmingly negative. A 2+ percentage point GDP share increase in manufacturing has essentially never happened in modern US economic history.

The Kalshi market shows 73% probability, but I believe this is significantly overpriced. EU accession is an extraordinarily lengthy process - no country has joined since Croatia in 2013, and the accession process typically takes a decade or more. The current candidate countries (Ukraine, Moldova, Western Balkans nations, etc.) are all in early stages of accession negotiations. Ukraine and Moldova only received candidate status in 2022, and even the most optimistic timelines don't project their accession before the mid-2030s. Montenegro and Serbia have been negotiating for over a decade with many chapters still open. The EU requires unanimous consent from all 27 member states, and there is no political consensus for rapid expansion. The accession process involves opening and closing 35 negotiating chapters, plus ratification by all member states. Given that we're looking at a deadline of January 1, 2030 (less than 5 years away), and no candidate country is close to completing negotiations, I see the true probability as quite low. The Kalshi market has low volume (75 contracts/day) which suggests the price may not be well-calibrated. I deviate strongly from the market price because the institutional and procedural barriers make accession by 2030 nearly impossible for any current candidate.

The Kalshi market prices this at 32%, but I believe this is significantly overpriced given the evidence. The most critical piece of information is Musk's February 2026 announcement that SpaceX is pivoting to prioritize the Moon, with Mars efforts beginning 'in about five to seven years' — meaning 2031-2033 at earliest. As of late 2025, Starship V2 was still in testing, V3 hadn't flown, orbital propellant transfer remained undemonstrated, and NASA was even reconsidering SpaceX's lunar lander contract due to delays. A Mars landing requires: completing Starship V3 development, demonstrating orbital refueling, building Mars-specific variants, and actually launching during a transfer window (the next ones are late 2026 and late 2028). With SpaceX explicitly deprioritizing Mars and the vehicle still far from operational readiness, making even a late-2028 window launch seems nearly impossible. The 32% market price likely reflects speculative optimism and Musk's historical ambitious claims rather than the hard technical and timeline constraints. I estimate roughly 8% probability, accounting for a small chance SpaceX could reverse course and attempt an unmanned cargo/test landing in the 2028-2029 window, but this would require extraordinary acceleration from where they currently stand.

The Kalshi market prices this at 44%, but I believe this is significantly overpriced. To resolve YES, a humanoid robot must physically walk on Mars before 2035 AND before any human does. Every piece of evidence points strongly against this: (1) No space agency or private company has announced plans to send a humanoid robot to Mars - all humanoid robot development is focused on terrestrial industrial applications; (2) SpaceX's Starship, the only plausible Mars transport vehicle, is struggling with repeated failures and can't even meet 2027 moon landing targets; (3) A Mars mission requires ~6-9 month transit plus landing capabilities that don't yet exist for heavy payloads; (4) Even non-humanoid Mars rovers take 5-10+ years from concept to landing; (5) There's no technical rationale for sending a humanoid robot vs. a purpose-built rover - humanoid form provides no advantage on Mars. The market at 44% seems to reflect speculative enthusiasm about humanoid robots and Mars rather than realistic assessment. Even Musk's most aggressive Mars timelines don't involve humanoid robots. The related markets showing only 16% for Mars colonization before 2050 and 30% for human Mars landing before 2050 further contextualize how unlikely any Mars surface mission is in this timeframe. I deviate strongly from the market price because the evidence is overwhelmingly negative with zero positive signals.

The Kalshi market prices this at 35%, but I believe this is significantly overpriced. The key ambiguity is what 'nuclear fusion is achieved' means - if it means net energy gain (Q>1), NIF already achieved this in December 2022 with ignition. If that counts, the market should be near 100%. Since it's trading at 35%, the market likely interprets this as something more ambitious - perhaps sustained/repeated net energy gain, or a demonstration of commercial viability. All research articles consistently point to fusion power being 'many years away,' with even optimistic private ventures not expecting commercial operation before 2030. The TAE Technologies facility hasn't even begun construction. China's EAST and other tokamaks are making incremental progress but nowhere near commercial fusion. The 7-day +5% move appears to be noise rather than signal given the low volume (~224/day). I deviate significantly downward from the market price because: (1) every expert source says commercial fusion before 2030 is extremely unlikely, (2) even scientific net-energy-gain fusion beyond NIF's single shots seems unlikely to be repeated reliably by 2030, and (3) Kalshi markets on niche topics with low volume tend to be less efficient. If the question is about any form of 'achieving' fusion including NIF's 2022 result, this should already be resolved Yes - suggesting the bar is higher, making sub-20% more appropriate.

The Kalshi market prices this at 16%, but I believe this is significantly too high given the evidence. The question requires not just a human landing on Mars, but a *self-sufficient colony* of 10+ people residing there for a full Earth year before 2050. Consider the chain of prerequisites: Starship must become reliable (still failing frequently as of late 2025), orbital refueling must be demonstrated, humans must first return to the Moon (not yet accomplished), life support systems for Mars must be developed and tested, and then multiple crewed missions must establish permanent infrastructure. NASA calls even a 2040 landing 'audacious,' and the related market gives only 10% to Elon Musk ever visiting Mars in his lifetime. The 'self-sufficient' requirement is extraordinarily demanding — even the ISS after 25 years of operation is not self-sufficient. Every piece of evidence points strongly toward NO: Starship development failures, untested orbital refueling, radiation/life support challenges, and the fact that a Moon base (the prerequisite) hasn't even begun construction. The 16% market price likely reflects retail optimism around Musk's rhetoric rather than sober engineering assessment. I deviate significantly downward to ~4%.

The Kalshi market prices this at 40%, but with only 1 day of data and low volume (81 contracts), the price may not be well-established. Key negative factors: (1) A clinical hold was placed on Intellia trials after a patient death from severe liver toxicity in late 2024/early 2025 - this is a major setback that could delay BLA submission by months or longer as Intellia would need to resolve safety concerns with the FDA before proceeding; (2) FDA institutional turmoil with key departures adds further uncertainty to regulatory timelines; (3) A BLA submission requires completion of pivotal trials and extensive data compilation, and clinical holds directly interrupt this process. The related market showing only 20% probability of FDA approval before July 2027 is informative - if there were only a ~35-40% chance of even submitting the BLA by Sep 2026, the approval probability by July 2027 (roughly 10 months later, within a standard 10-12 month review cycle) being only 20% is roughly consistent but suggests the market sees meaningful risk even after submission. Given the clinical hold and FDA instability, I shade slightly below the market price to 35%.

The Kalshi market prices this at 37%, but I believe this significantly overestimates the probability. A 'free trade agreement' with China that 'becomes law' is an extraordinarily high bar. The US has never had an FTA with China, and every piece of evidence points strongly against one materializing by January 2029. The October 2025 Trump-Xi truce left tariffs at ~20% minimum—far from free trade. All research articles consistently indicate the relationship involves truces and partial tariff reductions, not comprehensive FTAs. A true FTA would require Congressional ratification, which is politically inconceivable given bipartisan anti-China sentiment. China's record $1.1T trade surplus makes this even more politically toxic. The market title may be attracting speculators who conflate partial trade deals with formal FTAs, or the question wording may be ambiguous enough that traders interpret 'trade agreement' loosely. Historically, US FTAs take 5-10 years to negotiate even with friendly partners. I deviate substantially from the 37% market price because the fundamental political, economic, and procedural barriers are overwhelming—there is essentially no realistic pathway to a formal free trade agreement becoming law in this timeframe.

The Kalshi market prices this at 6%, but the evidence strongly suggests even that may be slightly high. While Rep. Kelly introduced impeachment articles against DHS Secretary Noem with 70 co-sponsors, Republicans control the House and have shown zero appetite for opposing Trump or his Cabinet. Noem was ultimately fired by Trump rather than impeached. House Democratic leadership explicitly stated they aren't pursuing impeachment before midterms, recognizing it's impractical without House control. The GOP-controlled House under Speaker Johnson has acted as a rubber stamp for the administration. Historically, Cabinet impeachment is extraordinarily rare (only one in U.S. history - Secretary Belknap in 1876). With Republicans in control through July 2026 and no realistic path to a House majority flip before then, I shade slightly below the market at 4%.

The Kalshi market prices this at 10%, but I believe this is inflated. Adding a new US state requires an act of Congress (simple majority in both chambers) plus presidential signature. The most discussed candidates are DC and Puerto Rico. Under Trump's administration (2025-2029), there is essentially zero chance DC statehood advances, as it would likely add Democratic representatives. Puerto Rico statehood is slightly more plausible given some Republican support, but there is no active legislative momentum, Puerto Rico's own political dynamics are complex, and Congress has shown no serious movement. The market price has been declining (down 3% in 7 days, down 5% in 30 days), suggesting the initial speculation that drove prices higher is fading. Historically, the last state added was Hawaii in 1959—66 years ago—making the base rate extremely low. The 10% market price likely reflects speculative interest and thin volume rather than genuine probability. I estimate ~4%.

The Kalshi market for 'Fed maintains rate' at the April 2027 meeting is priced at 66%, which is my primary anchor. The Fed cut rates three times in 2025, bringing the fed funds rate to 3.50%-3.75% by December 2025. The related market shows a 50% chance the rate is above 3.50% after the April 2027 meeting, consistent with the possibility that cuts continued but may have paused or reversed somewhat. The 26% probability of zero rate changes before 2027 (rising +9% in 7 days) suggests increasing uncertainty about continued cuts, possibly due to inflation concerns from tariffs and the Iran war mentioned in the ECB article. The 7-day price increase of +6% for the hold scenario suggests momentum toward a pause. With no strong evidence to deviate from the market price and moderate volume (180 contracts/day), I align closely with the market at 0.66.

The Kalshi market prices this at ~34%, but the evidence overwhelmingly points to NO. The U.S. and Iran entered full-scale military conflict starting February 28, 2026, with strikes on Iranian infrastructure, the killing of Iran's Supreme Leader, and Trump demanding unconditional surrender. Even before the war, severe sanctions had already reduced U.S.-Iran trade to near zero. Historical U.S. imports from Iran have been minimal (often under $5M) even in non-war years due to sanctions. With active warfare throughout 2026 and no diplomatic resolution in sight, legitimate U.S. imports exceeding $5M is extremely unlikely. The small residual probability accounts for the possibility of unusual categories (e.g., humanitarian goods, cultural items, or statistical anomalies in Census data) or a rapid peace deal followed by some trade resumption later in 2026. The market at 34% seems significantly overpriced given this evidence - possibly reflecting stale pricing or low-information trading.

The Kalshi market prices this at 10%, but I believe even that is too high. A >25bps hike (i.e., 50bps or more) at a single meeting would be extraordinarily rare and historically unprecedented in modern Fed policy outside of extreme crisis scenarios. As of late 2025, the Fed was in a cutting cycle with rates at 3.50-3.75%, and expert consensus projected further cuts into 2026. For a >25bps hike to occur by October 2027, we would need: (1) a dramatic inflation resurgence well above current levels, (2) a complete reversal of the easing cycle, (3) conditions severe enough to warrant not just a hike but an aggressive >25bps hike. Even during the 2022-2023 hiking cycle, the Fed started with 25bps moves before escalating. The related market showing ~50% probability of rates above 3.50% after April 2027 suggests the market sees rates roughly where they are now or lower, not dramatically higher. The 10% Kalshi price likely reflects thin trading (157 avg daily volume) and the wide bid-ask spreads common in low-probability event markets rather than genuine probability assessment. I discount to 4% reflecting the small but nonzero chance of a severe inflationary shock (e.g., major geopolitical escalation, supply chain collapse) that could force aggressive tightening.

The Kalshi market prices this at 6% with low volume (60 contracts/day), suggesting thin but directional pricing. Roy Lee is likely a content creator or entertainment figure whose current net worth is far below $1 billion. Becoming a billionaire before 2029 (roughly 3.5 years) is extremely rare for individuals not already on a clear trajectory (e.g., pre-IPO founders). The comparable Kai Cenat market at 8% for a longer timeframe (2030) with similar low volume suggests these are speculative, meme-driven markets. The 7-day price decline of 3% suggests cooling sentiment. Without any specific evidence of a major liquidity event (IPO, acquisition, etc.) that could catapult Roy Lee to billionaire status, I slightly shade below the market price to 5%, reflecting the general improbability of this outcome and the thin, possibly noise-driven nature of the market.

Current CO2 is at 430 ppm as of June 2025, with ~4.5 years remaining before Jan 2030. The annual CO2 increase has averaged about 2.0-2.5 ppm/year in recent years (with some years reaching ~3 ppm due to El Niño effects). To reach 440 ppm by Jan 2030, we'd need roughly 10 ppm of increase in ~4.5 years, requiring an average rate of ~2.2 ppm/year. This is within the range of recent trends but at the higher end. However, the 430 ppm figure is the seasonal peak (May/June), and annual mean CO2 for 2025 is likely around 426-427 ppm. The January 2030 reading would be a winter value (typically 2-3 ppm above the annual mean), so we'd need the annual mean to reach ~437-438 ppm by 2029, which requires ~11 ppm increase in ~4 years from ~427 — about 2.75 ppm/year consistently. This is possible but would require acceleration beyond typical rates. The Kalshi market at 86% seems significantly overpriced — it may be conflating peak seasonal readings with the threshold. Even with El Niño boosting some years and wildfires adding carbon, sustaining 2.75 ppm/year average growth for 4+ years is above the recent trend. I estimate roughly 15% probability, as this would require an unusually fast sustained acceleration in CO2 accumulation. The 30-day price decline of 9% on Kalshi suggests the market is correcting in this direction.

The Kalshi market prices this at 10%, which I find reasonable but perhaps slightly high. This question requires: (1) Musk surviving long enough (born 1971, so he'd be 127 by 2099 - life extension needed), (2) Mars transportation becoming human-rated and safe enough for a billionaire/CEO to personally travel, and (3) Musk actually choosing to go. Recent evidence is mixed-to-negative: SpaceX has shifted priority to the Moon, Starship still hasn't demonstrated orbital refueling, NASA contracts are uncertain, and Musk himself pushed Mars timelines out 5-7 years from the Moon effort. The related market shows only 27% chance of ANY human landing on Mars before 2050, and 21% for colonization by 2050. Even if humans eventually reach Mars (say 50-60% by 2099), Musk personally going requires him to be alive and healthy enough - he's currently 53, and a Mars trip likely wouldn't happen before he's 70+ at earliest. The combination of technical feasibility, Musk's survival, and his personal willingness to undertake an extremely dangerous journey makes this less likely than general Mars landing probabilities. I'll shade slightly below the market at 9%.

The Kalshi market prices this at 64%, and I find this broadly reasonable with a slight downward adjustment. Key evidence supporting YES: Blue Origin is aggressively reallocating resources (shuttering New Shepard) to focus on Blue Moon MK1, has a $3.6B NASA contract, and Blue Moon MK1 is architecturally simpler than Starship's lunar variant (which requires orbital refueling, a capability not yet demonstrated). SpaceX faces significant remaining technical hurdles - orbital refueling, Starship V3 development, and has had failures in 6 of 10 early test flights. NASA leadership has expressed concern about Starship delays and even suggested sidelining SpaceX. However, counterbalancing this: Musk's pivot to prioritizing the Moon could accelerate Starship development, SpaceX has a much faster iteration cadence than Blue Origin historically, and Blue Moon MK1 still needs New Glenn to be fully operational and reliable. The market at 64% reflects genuine uncertainty - Blue Moon is simpler but Blue Origin has less flight heritage, while Starship is more complex but SpaceX iterates faster. I shade slightly below the market at 62% given SpaceX's renewed lunar focus and historically faster development pace.

The Kalshi market prices US at 70% to be the first country to send humans to the Moon before Jan 1, 2031. The evidence strongly supports the US as the leading candidate: Artemis II (lunar flyby) is launching April 2026, NASA has restructured the program with a 2027 precursor mission and lunar landings targeted for 2028, and there's a $20 billion moon base plan. However, significant risks remain: SpaceX Starship still needs to demonstrate orbital refueling and other key capabilities, historical Artemis delays have been persistent, and the 2028 landing target has already been acknowledged as challenging (requiring additional preparatory steps). China is the main competitor with a ~2030 target but would need to beat the US. The question asks about 'launching a manned mission to the Moon' which could include flyby missions - Artemis II launching in April 2026 would qualify if 'to the Moon' includes lunar flyby. If so, the probability should be higher. But given the market is at 70% with moderate volume (291/day) and has been trending slightly upward, I'll stay close to market consensus, slightly discounting to 68% given the persistent history of schedule slippage in major space programs.

Trump nominated Kevin Warsh as Fed chair in January 2026, not Judy Shelton. Multiple articles from late 2025 and early 2026 consistently show Shelton was never in contention for the position, with Warsh and Hassett being the primary candidates. The Kalshi market prices this at 2%, which aligns with the evidence. The only residual probability comes from the unlikely scenario where Warsh's nomination fails and Trump pivots to Shelton, but given she wasn't even in the discussion, this is extremely unlikely. I see no reason to deviate from the market price of 2%.

The Kalshi market prices this at 10.7%, but the evidence strongly points toward NO. Every factual source confirms the SAVE Act passed the House but is blocked in the Senate by the 60-vote filibuster threshold. Democrats are unanimously opposed, and key Republican senators (including Murkowski and leadership) have firmly refused to eliminate the filibuster. As of late March 2026, the bill had no viable path to passage. With roughly 9 months remaining before the deadline, there's no indication of any mechanism to overcome these obstacles. The only scenario for YES would require either a dramatic filibuster rule change (which multiple senators have explicitly rejected) or Democratic defections (zero have occurred). I'm pricing slightly below the market at 6% because the evidence is overwhelmingly negative and the market volume, while decent, may reflect some speculative premium. The slight residual probability accounts for unlikely tail scenarios like a major political realignment or crisis that changes Senate dynamics.

Capital One announced it is acquiring Brex for $5.15 billion in January 2026, which effectively eliminates the possibility of Brex having an independent IPO. Since Brex will be absorbed into Capital One, it cannot IPO first (or at all). The Kalshi market already reflects this at 7% for Brex, which accounts for some residual uncertainty around whether the acquisition could fall through due to regulatory issues or other complications. However, the deal is confirmed by both sides and involves a major bank with strong deal-closing capabilities. The 7% market price likely slightly overestimates the chance of deal failure; I'd put it at around 4%, accounting for a small but real probability that the acquisition collapses and Brex then somehow IPOs before Ramp in the remaining years before 2040.

The Kalshi market prices Anthropic IPOing first at 51%, but the evidence strongly favors OpenAI going public first. OpenAI is actively preparing for an IPO with investor documents resembling a prospectus, banking partners for a $10B round, and reports suggesting a debut 'as soon as this year' (2026) at a $730B valuation. The related market gives a 59% chance OpenAI announces an IPO before Jan 1, 2027. Meanwhile, none of the Anthropic articles mention any IPO plans—Anthropic is currently embroiled in government contract disputes and safety policy debates. Anthropic's corporate structure as a Public Benefit Corporation with unique governance may also complicate an IPO path. Given OpenAI's concrete IPO preparations versus zero evidence of Anthropic IPO planning, I deviate significantly from the 51% market price downward to ~35% for Anthropic going first. The market may be overpricing Anthropic due to the long time horizon (until 2040), but OpenAI's near-term IPO momentum makes it substantially more likely to go first.

The Kalshi market prices recession at 40%, with a significant upward trend (+19% over 30 days). Key evidence: Q4 2025 GDP slowed to 1.4% annualized, the U.S.-Iran war has caused major oil supply disruptions (Strait of Hormuz largely closed, oil near $119/barrel, gas approaching $4/gallon), and Goldman Sachs raised recession odds to 30%. However, several counterweights exist: the economy showed strong 4.3% growth in Q3 2025, Wall Street largely dismissed Q4 weakness as shutdown-related, and economists were wrong about tariff-induced recession in 2025. Importantly, the question requires TWO consecutive quarters of negative GDP growth (the traditional technical recession definition), which is a higher bar than the NBER definition the Kalshi market may be tracking. Even with oil shocks and slowing growth, going from +1.4% GDP growth to two consecutive negative quarters requires a significant deterioration. I shade slightly below the market price at 35% because the two-consecutive-negative-quarters threshold is harder to meet than a general 'recession' call, and the economy entered 2026 with meaningful positive momentum despite headwinds.

The Kalshi market prices this at 84.8%, and the evidence strongly supports this level. The question asks whether information sector layoffs in 2026 will exceed 447,000. Key facts: (1) Through November 2025, tech led with 153,536 layoffs, and total employer cuts were 1.1M (54% above 2024). (2) January 2026 saw 108,435 total job cuts (118% above Jan 2025), with 22,291 in tech alone. (3) February 2026 saw nonfarm payrolls fall by 92,000. (4) AI-driven layoffs are accelerating—55,000 cuts cited AI in 2025, and pressure to demonstrate AI ROI is intensifying in 2026. (5) Major employers like Amazon are executing multi-wave layoffs extending into 2026. The 447K threshold for the information sector specifically is high, but the trajectory is clearly worsening. If January's tech layoff pace (~22K) is even roughly representative, that alone would annualize to ~264K, and the trend appears to be accelerating with macro headwinds. I see no strong reason to deviate from the market price, which already incorporates this information.

The Kalshi market prices this at 44%, but I'm slightly more skeptical. This requires BOTH 235+ House seats AND 51+ Senate seats for Democrats. The related 'D-House, D-Senate' balance of power market is at 47%, which is simply Democrats winning both chambers - a lower bar than 235+ seats specifically. The research consistently notes that while Democrats are favored to win the House, the map is narrow due to redistricting and polarization, making 235+ seats (a net gain of ~20 seats) ambitious - analysts compare this unfavorably to 2018's wave. Democrats need only 3 seats for a majority but getting to 235 requires a genuine wave. The Senate is competitive but not clearly favoring Democrats. The financial disadvantage ($81M behind RNC), Republican redistricting efforts, and Trump administration's election rule changes all create headwinds. The 30-day trend is +8% suggesting improving Democratic prospects, but I weight the structural analysis suggesting 235+ is a high bar. Since the combo market at 44% already reflects some optimism, and the evidence suggests 235+ is significantly harder than simply winning the House, I shade slightly below market.

The market is priced at 84%, but the evidence strongly supports a higher probability. As of October 2025, approximately 154,000 employees accepted buyout offers and were largely removed from payroll by end of September, plus 105,000 took regular retirement (an 18% surge). These numbers already massively exceed the 50,000 threshold relative to any reasonable baseline. Even accounting for some rehiring, court-ordered pauses on new RIFs, and potential reversals, the net reduction from December 2025 levels is almost certainly well above 50,000. The question measures employees 'no longer working relative to December 2025,' and since much of the attrition occurred before December 2025, I need to consider what happens after that date — but the ongoing RIF waves, continued retirements, hiring freezes, and DOGE-driven cuts make it very likely additional reductions exceed 50,000 even from a December 2025 baseline. The 84% market price may reflect uncertainty about exact measurement methodology or legal reversals, but the magnitude of cuts is so large that I'm confident this resolves Yes.

The Kalshi market prices this at 13%, but I believe this significantly overstates the probability. The most critical evidence is that the Supreme Court declined to hear the Kim Davis case in November 2025 without any noted dissent, which is the strongest possible signal that the Court will not revisit Obergefell. No case challenging same-sex marriage is on the 2025-2026 docket, and for the Court to overturn Obergefell by Jan 1, 2029, a case would need to be filed, granted cert, briefed, argued, and decided — a process taking 1-2 years minimum. Only Justice Thomas has publicly called for revisiting Obergefell; Barrett's public statements suggest she would not support overturning it; and the Respect for Marriage Act provides additional statutory protection. With 68-70% public support, no vehicle case, and the Court having just refused to take up the issue, the probability is extremely low. The Kalshi market at 13% likely reflects speculative/political anxiety rather than legal reality. I deviate substantially downward because the factual evidence is overwhelmingly against this outcome.

The Kalshi market prices this at 32%, but I believe this significantly overestimates the probability. The evidence strongly suggests the US strategy is to remove Chinese influence from the Panama Canal through diplomatic and legal pressure on Panama, NOT to take direct control. Panama's Supreme Court already voided CK Hutchison's port concessions—a major US win achieved without any seizure. Taking 'control of at least some part of the Panama Canal' would require either military action against a sovereign ally, a negotiated transfer of sovereignty/operational control, or some unprecedented arrangement—all of which face enormous legal, diplomatic, and practical barriers. The US has no legal basis, Congress would likely oppose military action against an ally, and Panama has been cooperative in addressing US concerns about Chinese influence. The 1977 Carter-Torrijos treaties ceded the canal to Panama with broad international support; reversing this would be extraordinarily provocative. While Trump has made rhetorical statements about 'taking back' the canal, his administration's actual actions have been conventional diplomatic pressure. I deviate substantially from the Kalshi price because I believe that market reflects speculative interest driven by Trump's rhetoric rather than realistic assessment of execution probability. The market may also be inflated by retail traders overweighting dramatic scenarios.

The Kalshi market prices this at 22%, but I believe this overestimates the probability. The evidence consistently shows that while the Trump administration has aggressively hollowed out the Education Department through layoffs, interagency transfers, and vacating headquarters, every credible source confirms that formal elimination requires congressional action needing 60 Senate votes. As of late 2025/early 2026, Congress has taken 'virtually no steps' toward such legislation, and getting Democratic support for a 60-vote threshold is extremely unlikely. The administration's strategy appears to be functional dismantlement rather than formal elimination. The question specifically asks about the department being 'sunsetted or eliminated entirely,' which requires legislation. The 7-day price trend is declining (-3%), consistent with growing recognition that administrative gutting ≠ formal elimination. Historical base rate: no Cabinet-level department has ever been formally eliminated by Congress. I deviate below the market price because the structural legislative barriers are nearly insurmountable given current Senate composition and the lack of any legislative momentum.

The Kalshi market prices this at 28%, but I believe this significantly overestimates the probability of an actual *purchase*. The evidence is overwhelmingly against a sale: Denmark and Greenland firmly reject sovereignty transfer, European allies have drawn red lines, high-level Vance-Denmark talks ended in 'fundamental disagreement,' and even Trump advisers prefer alliance/lease arrangements over outright purchase. The related 'No Acquisition' market at 76% (implying ~24% chance of purchase) is more consistent with the main market. However, the 'US take control' market at 37% being higher than the 'purchase' market at 28% suggests the market sees non-purchase control scenarios (lease, military base expansion, security agreement) as more likely than outright purchase. A purchase requires willing sellers — Denmark's parliament and Greenland's government — and there is zero indication either would agree. Historical precedent (Trump's 2019 attempt was flatly rejected) and the current diplomatic impasse suggest the base rate for sovereign territory purchases against the seller's will is essentially zero. The only scenario for YES would be some creative deal structure that technically counts as purchasing 'at least part' of Greenland, but even partial land sales face the same sovereignty objections. I deviate substantially below the market price because I believe the market is pricing in speculative scenarios that don't meet the specific 'purchase' criterion.

The Kalshi market prices this at 23%, which seems significantly too high given the structural barriers. Impeachment requires a House majority vote AND a 67-vote Senate supermajority for conviction/removal. Even if Democrats win the House in 2026, they would need ~17 Republican senators to vote to convict - an unprecedented level of party defection. The evidence shows: (1) Democrats currently lack House control and are deliberately not pursuing impeachment, (2) Senate Republicans have broadly backed Trump's agenda with no significant dissent bloc, (3) Even Democratic leaders describe impeachment as 'not only impractical' but potentially counterproductive. Historical base rate: no president has ever been impeached AND removed. Trump was impeached twice before without conviction, even after January 6th when circumstances were far more acute. The Kalshi price at 23% likely reflects speculative/retail sentiment rather than calibrated probability. I deviate substantially downward because the structural requirement of 67 Senate votes makes removal virtually impossible absent an extraordinary scandal that fractures the Republican party far beyond anything currently visible.

The Kalshi market prices this at 13%, but I believe this is significantly overpriced. The acquisition of any part of Canada by the US before 2029 would be an unprecedented event requiring either: (1) a negotiated transfer of territory, which Canada's government is actively opposing with strengthened sovereignty rhetoric and diversified alliances (EU partnership, Carney's Davos speech); (2) a military conquest, which is essentially unthinkable between two NATO allies and nuclear-armed nations; or (3) a voluntary secession vote by a Canadian province followed by US annexation, which even the Alberta secession market only prices at 15% and would require multiple additional steps. The base rate for peaceful territorial acquisition between developed democracies in the modern era is essentially zero. US-Canada relations are characterized by trade friction, not territorial negotiation. The Kalshi price likely reflects speculative interest driven by Trump's rhetoric about Canada becoming the 51st state, but rhetoric is vastly different from actual territorial acquisition. I deviate strongly downward from the market price because there is no plausible mechanism for this to occur within the ~3-year timeframe.

The Kalshi market for this specific question (acquiring any part of Greenland before 2029) is at 37%, while the related 'no acquisition' price market is at 76% (implying ~24% chance of acquisition), and the 'buy' market is at 28%. There's a notable discrepancy between the 37% main market and the ~24-28% from related markets. The evidence overwhelmingly points toward NO: the Vance-Denmark meeting ended in 'fundamental disagreement,' Greenland's PM insists on sovereignty red lines, Denmark warns acquisition would end NATO, European allies are firmly opposed, Greenlandic public opinion is strongly against it, and even Trump advisers prefer negotiation over force. The 'framework of a deal' Trump mentioned at Davos appears to be about security/minerals cooperation, not territorial acquisition. Acquiring sovereign territory requires either purchase (both seller parties refuse), military action (would destroy NATO and face massive domestic/international opposition), or a referendum in Greenland (population strongly opposed). With ~3 years remaining, these obstacles are enormous. I'm deviating significantly below the 37% market price because I believe the market overprices tail-risk scenarios and speculative momentum from Trump's rhetoric. The related markets at 24-28% are more consistent with fundamentals, and even those seem high given the near-impossibility of completing a territorial transfer against the wishes of both the selling government and the local population within this timeframe.

The Kalshi market prices this at 24%, but I find this significantly overpriced. Every piece of evidence from the research summary—spanning over a year of Trump's second term through March 2026—shows a president who is aggressively governing, expanding power, waging wars, reshaping institutions, and actively working to maintain political control through midterms. There is zero indication of resignation intent. Historical base rates are extremely relevant: only one president (Nixon) has ever resigned, and that required an extraordinary convergence of bipartisan impeachment support, Supreme Court rulings against him, and loss of his own party's backing. Trump at 78 could face health issues, but even then presidents historically don't resign for health reasons (they invoke the 25th Amendment temporarily or serve through illness). The 24% market price likely reflects speculative interest and the long time horizon (3+ years remaining), but the volume is relatively low (470/day) suggesting thin liquidity that can push prices away from fair value. I'm discounting the market price substantially to ~12%, reflecting a small but non-trivial chance of health emergency or unprecedented political crisis forcing resignation over the remaining ~3 years of his term, while recognizing that all current evidence strongly points to NO.

The Kalshi market prices this at ~16%, but the evidence strongly suggests this is overpriced. Manufacturing's share of GDP has been in secular decline for decades - it was around 11-12% in recent years, and reaching 13.1% (2005 levels) by Q4 2028 would require an unprecedented reversal. The evidence shows: (1) manufacturing is actually losing jobs in 2025 despite tariffs, (2) the Supreme Court struck down Trump's emergency tariffs, undermining his primary policy tool, (3) China is circumventing tariffs through transshipment, (4) modern manufacturing is capital-intensive and low-employment, not the mass-scale revival needed to move GDP share by 1-2+ percentage points, and (5) tariff chaos makes long-term investment planning difficult. Even with aggressive reshoring efforts, supply chain experts note meaningful gains wouldn't appear until 2026-2027, leaving very little time to achieve a massive structural shift by Q4 2028. The 30-year structural trend away from manufacturing GDP share, combined with active policy failures, makes this extremely unlikely. I deviate below the Kalshi price because the market may be reflecting speculative hope rather than economic fundamentals.

The Kalshi market shows 73%, but I believe this is significantly overpriced. EU accession is an extremely lengthy process requiring unanimous consent from all 27 member states, completion of 35 negotiating chapters, and years of institutional preparation. The current candidate countries (Montenegro, Serbia, Albania, North Macedonia, Moldova, Ukraine, Bosnia & Herzegovina, Georgia, Turkey) all face major obstacles. Montenegro is the most advanced but still has significant rule-of-law issues and has been negotiating since 2012 with no end in sight. Ukraine and Moldova received candidate status in 2022 but are years away from meeting accession criteria. Historically, the fastest accession after receiving candidate status took about 6 years (Finland), and most take 8-12+ years. No country is currently in the final stages of accession negotiations with a realistic timeline to join before January 2030. The Kalshi volume is quite low (75 contracts/day), suggesting the price may not be well-calibrated. I estimate approximately 25% probability, accounting for a small chance of an accelerated political decision (perhaps for a smaller Western Balkans country like Montenegro) but recognizing that the institutional and political barriers make pre-2030 accession highly unlikely.

The Kalshi market prices this at 28%, but the evidence strongly suggests this is overpriced. As of February 2026, Musk himself pivoted SpaceX's priority to the Moon, saying Mars city construction would begin in 'about five to seven years' (2031-2033). Starship remains in early test flight phases - as of late 2025, it had not achieved orbit, orbital refueling, or full reusability, all prerequisites before any Mars attempt. Mars launch windows occur roughly every 26 months (next opportunities: late 2026, early 2029), and SpaceX would need a vehicle far more mature than current Starship to attempt even an uncrewed Mars landing. The 2026 window is essentially impossible given current development status, and the 2028-2029 window would require extraordinary acceleration of a program that is behind schedule even for nearer-term Moon missions. NASA is considering dropping SpaceX from its lunar lander contract due to delays. I deviate significantly below the market price of 28% because the cumulative evidence - priority shift to Moon, development delays, failed test flights, regulatory challenges, and the physics of Mars transfer windows - makes a pre-2030 Mars landing extremely unlikely. A probability around 5-7% accounts for the small chance SpaceX dramatically accelerates development and attempts a minimal uncrewed landing during the 2028-2029 window.

The Kalshi market prices this at 47%, but I believe this is significantly overpriced based on the evidence. The question requires a humanoid robot to physically walk on Mars before 2035. This requires: (1) a Mars landing mission capable of delivering a humanoid robot, (2) a humanoid robot capable of functioning on Mars, and (3) all of this before any human lands on Mars (which itself is extremely unlikely before 2035). Currently, Starship - the only vehicle with plausible Mars cargo capacity - is still failing test flights and hasn't demonstrated orbital refueling. NASA has no Mars mission planned before 2035, and even lunar landings are slipping to 2028+. No entity (SpaceX, NASA, China) has announced concrete plans to send a humanoid robot to Mars. All humanoid robot development is focused on terrestrial commercial applications. Even SpaceX's most optimistic Mars cargo mission timelines (uncrewed) have repeatedly slipped. The transit time alone is 6-9 months, meaning a mission would need to launch by early 2034 at the latest, requiring mission planning to begin years before that. The related markets show only 27% chance of a human landing on Mars before 2050 and 21% for colonization before 2050, which contextualize how difficult Mars access is. I deviate sharply from the 47% market price because the evidence overwhelmingly suggests this is extremely unlikely within the timeframe - the market volume is moderate but this seems like a speculative/entertainment market where prices may not reflect careful analysis.

The Kalshi market prices this at 35%, but I believe this is significantly overpriced. The key question is what 'nuclear fusion is achieved' means - if it means a sustained, commercially viable fusion reaction or net-energy gain from a power plant, this is extremely unlikely before 2030. NIF achieved scientific breakeven (ignition) in December 2022, but that's already happened. For a NEW milestone like sustained net energy or commercial fusion: Commonwealth Fusion Systems' SPARC isn't expected to demonstrate net energy until the late 2020s at earliest, and commercial fusion is described as 'roughly a decade away.' All expert sources consistently indicate fusion power plants are many years away. The 35% market price likely reflects ambiguity in resolution criteria - if 'achieved' means any net-energy demonstration, NIF already did it; if it means something more, it's very unlikely by 2030. Given the research unanimously points to NO direction and that no facility is close to sustained commercial fusion, I deviate substantially downward from the market price. The market's relatively low volume (226/day) and wide price range (9-51%) suggest significant uncertainty and possible mispricing. I estimate ~12% accounting for some small chance of an unexpected breakthrough or favorable resolution criteria interpretation.

The Kalshi market prices this at 21%, but I believe this is significantly overpriced given the evidence. The question requires a *self-sufficient colony* of 10+ people living on Mars for a full year before 2050 — not just a landing. As of late 2025, Starship hasn't achieved orbital refueling, has failed 6 of 10 test flights, and NASA's focus is on a $20B moon base program as a *precursor* to Mars. Even optimistic SpaceX timelines target first uncrewed cargo ships in 2026-2028, with NASA calling a 2040 Mars arrival 'audacious.' A self-sufficient colony requires not just landing but sustained life support, habitat construction, resource extraction (ISRU), and supply independence — capabilities that don't exist even in prototype form. The related market showing only 10% for Elon Musk visiting Mars *in his lifetime* and 27% for any human *landing* on Mars before 2050 make 21% for a self-sufficient colony logically inconsistent. Historically, space development timelines slip dramatically (ISS took decades; Artemis is years behind). I place this at ~3%, reflecting that while not impossible, the engineering, funding, and political hurdles make a self-sufficient 10-person colony by 2049 extraordinarily unlikely.

The Kalshi market prices this at 53% with very limited trading data (only 1 day of data, 92 contracts average volume). This is a thin market with minimal price discovery, so the signal is noisy. Beam Therapeutics' risto-cel (BEAM-101) is a gene-editing therapy for sickle cell disease. BLA submissions are complex regulatory milestones that often face delays. Without specific research summaries to indicate the current stage of clinical development, manufacturing readiness, or any announced BLA submission timeline, I must rely heavily on the market price. The timeline to December 2026 gives roughly 18 months, which is a reasonable but not guaranteed window for a BLA submission if the company is in late-stage trials. Given the thin market and lack of confirming evidence, I anchor near the market price at 52%, slightly discounting due to the general tendency for drug development timelines to slip and the absence of concrete evidence supporting an imminent submission.

The Kalshi market prices this at 39% with only 2 days of trading data and modest volume (219 contracts/day), suggesting the price is not yet well-established. Key factors weighing against approval before Oct 2027: (1) As of March 2026, COMP360 has not received FDA approval and psilocybin remains Schedule 1 federally; (2) The FDA has been in a stricter regulatory posture, denying/discouraging multiple drug applications citing insufficient evidence; (3) COMPASS Pathways' Phase 3 trials have had mixed results historically, and the therapy involves complex administration requirements (trained therapists, controlled settings) that complicate the regulatory pathway; (4) Even if an NDA were filed soon, the typical review timeline of 10-12 months plus potential advisory committee meetings and possible Complete Response Letters make Oct 2027 tight. The positive signals (breakthrough therapy designation, growing evidence base for psilocybin) provide some upside. I'm slightly below the market price at 37% because the FDA's recent pattern of stricter scrutiny and the complexity of approving a Schedule 1 psychedelic therapy with mandatory therapeutic support suggest the market may be slightly optimistic.

The Kalshi market prices this at 3%, and the evidence strongly supports a low probability. Two override attempts on bills that passed unanimously both failed in January 2026, with only 24-35 Republican defections - far short of the two-thirds needed. A March 2026 article describes Congress as a 'rubber stamp' for Trump, indicating no shift in dynamics. Historically, veto overrides are rare even in divided government; with Republicans controlling both chambers and showing strong party loyalty to Trump, an override before March 1, 2026 is extremely unlikely. With the deadline now very close and no pending override votes apparent, I price this slightly below the market at 2%.

The Kalshi market prices this at 13%, but the evidence strongly suggests this is overpriced. The Supreme Court explicitly rejected the most direct challenge to Obergefell (Kim Davis case) in November 2025 without comment, with the 6-3 conservative majority declining to take it up. Only Justice Thomas has called for reconsidering Obergefell. Justice Barrett's comments suggest judicial restraint rather than activism on this issue. The Trump administration notably did not push for reversal. Public support for same-sex marriage is at 68%, and the Respect for Marriage Act provides a legislative backstop. For this to resolve YES by Jan 2029, the Court would need to grant cert on a new case, brief it, argue it, and issue a ruling overturning Obergefell — all within ~3 years, after just declining the most viable vehicle. The combination of no willing petitioner pathway, insufficient votes (likely only Thomas), strong public support, and the Court's demonstrated unwillingness to revisit this makes the probability extremely low. I deviate significantly below the 13% market price because the Kim Davis denial is near-dispositive evidence.

The Kalshi market prices this at 1%, and all available evidence strongly supports this. As of March 19, 2026 — just 12 days before the April 1 resolution deadline — Bondi is still actively serving as AG, testifying before Congress, defending DOJ actions, and being named in lawsuits. There are zero reports suggesting she is considering resignation or that Trump is considering removing her. The related market gives a 32% chance Trump has only 1 AG total (through his term), which is consistent with Bondi staying well past April. The price has been declining from 18% to 1% as the deadline approaches without any departure. With only ~12 days remaining and no credible signals of departure, 1% is appropriate.

The Kalshi market prices this at 11%, down 6% over the past week, suggesting fading momentum. While FHFA Director Pulte and Trump signaled interest in privatization in early 2026, the timeline has repeatedly slipped — Pulte said a decision would come 'in the next month or two' back in January 2026, yet by March 2026 Fannie Mae is still under conservatorship with no IPO announced. An IPO of this magnitude (involving massive GSEs that back trillions in mortgages) requires extensive regulatory, legal, and financial preparation — capital adequacy requirements, Treasury negotiations over the senior preferred stock, SEC filings, and political consensus. Historically, GSE reform has been discussed for over a decade without resolution. The declining market price reflects growing skepticism that a formal IPO announcement can happen before June 2027. I slightly shade below the market at 9%, reflecting the persistent pattern of delays and the lack of any concrete IPO filing or announcement as of the latest evidence.

The Kalshi market prices this at 65%, but with a sharp 15% drop in the last 7 days and 34% drop over 30 days, momentum is clearly bearish. The research paints a challenging picture for US rig counts: oil prices started 2026 below $60/barrel with global oversupply, which would suppress drilling. While the US-Iran war spiked prices to $107/barrel by mid-March, the articles emphasize this creates economic uncertainty that deters investment rather than encouraging it. Oil companies have shown reluctance to expand aggressively. The current US rig count has been trending down from ~480 in late 2024 toward the low-to-mid 400s range. With prices volatile, trade war uncertainty, and industry capital discipline, reaching 430 by year-end is uncertain. The rapid market decline suggests new information is being processed that's bearish. I shade below the current market price of 65% given the strong downward momentum and consistently negative signals from research, estimating roughly 45%.

Brex has been acquired by Capital One for $5.15 billion as announced on January 22, 2026. This acquisition makes an independent IPO essentially impossible before May 1, 2026. The Kalshi market reflects this at 3%, and the related 'Ramp or Brex IPO first' market prices Brex at just 2%. The only scenario where this resolves Yes would be if the Capital One deal falls through AND Brex somehow rushes an IPO in the remaining months, which is extraordinarily unlikely. I'm setting this at 2%, aligned with the lowest related market price, reflecting the near-zero but non-zero chance of deal collapse combined with an emergency pivot to IPO.

The research evidence is overwhelming and factual: multiple sources confirm the federal workforce shrank by over 242,000 net employees by December 2025, with 300,000+ total departures by March 2026. The 50,000 threshold has been exceeded by roughly 5-6x. The Kalshi market at 84% appears underpriced relative to this evidence — possibly reflecting residual uncertainty about measurement methodology or legal reversals forcing reinstatements. However, even if courts ordered widespread reinstatements, the scale of cuts (300,000+) makes it nearly impossible to bring the net reduction below 50,000. The only risk factor would be definitional disputes about the baseline (December 2025 count) vs. earlier counts, but the market description is clear. I deviate upward from the 84% market price because the factual evidence from OPM data is definitive and the threshold has been massively surpassed.

As of June 2025, atmospheric CO2 reached 430 ppm. The annual CO2 increase has been approximately 2.5-3 ppm/year in recent years. To reach 440 ppm before January 2030, we need roughly 10 ppm increase over ~4.5 years, requiring ~2.2 ppm/year — well within the current trend. However, the question likely refers to the peak monthly average (typically May/June), since CO2 has a seasonal cycle with ~6-7 ppm amplitude. The June 2025 reading of 430 ppm is near the seasonal peak; the annual average is closer to 426-427 ppm. By 2029, the seasonal peak would be around 437-442 ppm at current rates (~2.5-3 ppm/year growth). This makes reaching 440 ppm likely but not certain — a slight slowdown in emissions growth (as suggested by China's declining emissions) or a favorable year could keep the peak just below 440. The Kalshi market at 86% has been declining (from 95% to 84-86%), suggesting traders are becoming slightly less confident, possibly factoring in China's emissions decline and measurement uncertainty. I slightly discount from the market price to ~82%, reflecting the real possibility that the seasonal peak in 2029 lands just below 440 ppm if emission growth moderates, plus some resolution ambiguity about which measurement standard is used.

The Kalshi market prices this at 9%, which I find reasonable but perhaps slightly generous. Key considerations: (1) Musk was born in 1971, so he'll be 127 by 2099 - he needs to both survive long enough AND have the technology ready during his lifetime. His actuarial life expectancy puts him living to roughly 2040-2055 range. (2) SpaceX has shifted priority to the Moon, with Mars crewed missions pushed further out. Even uncrewed Mars landings keep slipping. (3) The related market shows only 29% chance of ANY human landing on Mars before 2050, and only 21% for colonization by 2050. For Musk specifically to visit, he'd need to be alive and healthy enough for a Mars journey (6+ months each way), which becomes increasingly unlikely as he ages. (4) Even if crewed Mars missions happen by the 2040s-2050s, the first crews would likely be younger, trained astronauts - not a 70-80+ year old. (5) Breakthroughs in longevity science could extend his life, but this is speculative. I'll shade slightly below the market at 8%, reflecting the compounding improbability of technology readiness during Musk's healthy lifespan AND his being selected/choosing to go personally.

The Kalshi market prices this at 63%, and the evidence broadly supports a probability in this range. Key factors favoring YES: Blue Origin is redirecting resources from New Shepard to Blue Moon development, SpaceX's Starship faces significant unresolved technical challenges (orbital refueling never attempted, multiple test failures), and NASA officials have expressed concerns about Starship delays with the acting chief even suggesting SpaceX could be sidelined. Key factors favoring NO: SpaceX has achieved back-to-back successful Starship flights and Musk has announced a pivot to prioritize lunar missions, SpaceX has a track record of eventually overcoming technical challenges, and the Artemis restructuring adding preparatory flights affects both programs. Blue Moon MK1 is a smaller, less complex vehicle than Starship for a lunar landing, giving it a plausible development advantage, but Blue Origin has its own history of delays. I shade slightly below the market at 60% because Musk's renewed lunar focus and SpaceX's rapid iteration capability represent meaningful catch-up potential, though the complexity gap between the two vehicles keeps Blue Origin as the slight favorite.

The Kalshi market prices US at 70% to be the first country to send humans to the Moon before 2031. The evidence strongly supports this: NASA's Artemis program is actively progressing with Artemis II (lunar flyby) preparing for launch in early 2026, and NASA has announced a restructured but committed plan with $20 billion for a moon base. The key risk is that Artemis III was restructured to stay in Earth orbit, pushing actual lunar landing to Artemis IV/V, and Starship development faces significant delays with key milestones like orbital fuel transfer undemonstrated. China targets 2030 but is currently focused on its space station. The question asks about 'manned mission to the Moon' which could include flyby missions like Artemis II (which goes around the Moon), not just landings. If flyby counts, the probability is higher since Artemis II is imminent. Given the strong US commitment, restructured but progressing timeline, China's later target date, and the market at 70%, I slightly adjust upward to 72% reflecting the near-term Artemis II launch if flyby missions qualify.

The Kalshi market prices Judy Shelton at 2.2% probability, which I find well-calibrated. None of the research articles mention Shelton as a candidate for Fed chair — Trump is reportedly seeking a new chair who supports lower interest rates, but Shelton isn't named. Shelton was previously rejected by the Senate for a Fed governor seat in 2020, which creates a significant confirmation hurdle. The market has been trending downward (from ~5% to ~2%) over the past month, suggesting diminishing likelihood. Other candidates like Kevin Warsh or Kevin Hassett have been more prominently discussed. Without any concrete evidence of her nomination, the market price of ~2% appropriately reflects a small but non-zero tail probability.

The Kalshi market prices this at 10.7%, and the evidence strongly supports a low probability. Every factual source confirms the SAVE Act cannot overcome the Senate's 60-vote filibuster threshold. Senate Majority Leader Thune explicitly stated he lacks the votes, Democrats are unanimously opposed, and multiple Republican senators (including Murkowski and Tillis) have firmly rejected eliminating or weakening the filibuster despite Trump's pressure. Even Trump's threat to withhold signing other legislation hasn't moved the needle. The 30-day price trend is slightly downward (-1.3%), consistent with the bill's prospects dimming. I shade slightly below the market at 8% because the evidence is uniformly negative — there is no plausible path to 60 Senate votes, and filibuster reform appears dead. The only slim scenario would involve some unprecedented deal or reconciliation maneuver, but voting legislation doesn't qualify for budget reconciliation. The remaining ~8% accounts for tail risks like dramatic political shifts or creative legislative packaging.

The key factual development is that Capital One announced its acquisition of Brex for $5.15 billion in January 2026. If this deal closes, Brex will become part of Capital One and cannot independently IPO, meaning Ramp would IPO first (or neither would, but Brex certainly wouldn't IPO independently). The Kalshi market currently prices Brex at 2%, reflecting this acquisition news. There's a small residual probability that the Capital One-Brex deal falls through due to regulatory issues or other complications (similar to how some large acquisitions fail), which could restore Brex's independent IPO path. However, even if the deal fails, Brex would still need to IPO before Ramp over a long time horizon. I set my estimate slightly above the market at 3% to account for some small probability the deal collapses AND Brex then beats Ramp to IPO, but this is a very unlikely chain of events.

The Kalshi market prices Anthropic IPOing first at 63%, but I find strong reasons to deviate downward. The evidence overwhelmingly points to OpenAI being far closer to an IPO: OpenAI has shared an IPO-like prospectus with investors, is valued at $730B, generated $13.1B in 2025 revenue, and multiple sources describe an IPO 'as soon as this year.' The related market gives OpenAI a 58% chance of announcing an IPO before Jan 1, 2027. Meanwhile, Anthropic has zero reported IPO preparations, is embroiled in legal battles with the Trump administration over Pentagon contracts, and is navigating significant regulatory and strategic challenges. The 7-day +21% spike in the Anthropic market suggests possible noise or a speculative move rather than fundamentally justified repricing. Given OpenAI's concrete IPO preparations versus Anthropic's complete absence of IPO signals, I estimate roughly 30% probability that Anthropic IPOs first, significantly below the current market price.

The Kalshi market prices recession probability at 35%, which I use as my anchor. The evidence is mixed but leans toward elevated risk: Q4 2025 GDP slowed to 1.4% annualized, the Iran war/Strait of Hormuz disruption is driving energy prices sharply higher (Goldman at 30% recession odds, EY at 40%), reduced immigration is a GDP drag, and AI's growth contribution may be overstated. However, the resolution criterion is specifically two consecutive quarters of negative GDP growth, which is a high bar — the U.S. has only experienced this a handful of times in recent decades. Even with 1.4% Q4 2025 growth and significant headwinds, going from slow growth to actual contraction for two straight quarters requires a substantial shock. The Iran war/energy price spike is the most credible catalyst, but the administration has tools (Fed rate cuts, fiscal stimulus ahead of midterms) to cushion the blow. Private forecasters still see 2-3% growth as the base case. I shade very slightly below the market at 33%, as the two-consecutive-quarters requirement is a stricter threshold than a general NBER recession call.

The Kalshi market prices this at 85.2%, and the evidence strongly supports this level. The threshold is 447,000 information sector layoffs in 2026. January 2026 alone saw 108,435 total job cuts (highest January since 2009), with tech as the second-highest sector. Multiple structural drivers are accelerating layoffs: AI-driven workforce reductions (55,000 attributed to AI in 2025 alone), major companies like Amazon cutting 16,000+ in early 2026, and a broader corporate mindset shift treating headcount cuts as signs of vitality. The 2025 baseline already showed ~950,000 cuts through September, suggesting the 447,000 threshold for the information sector specifically is achievable given these trends are intensifying. Additional risk factors (AI bubble concerns, PE credit risks, government contract uncertainty for tech firms) all point toward sustained or increasing layoff activity. The 30-day price increase of +14.2% reflects markets digesting the strong January data. I see no strong contrarian case - the economy would need a dramatic positive reversal to keep information sector layoffs below 447,000 for the full year. I align closely with the market at 0.85.

The Kalshi market for this exact question prices it at 45%, while the related 'D-House, D-Senate' balance of power market is at 47.5%. The key distinction is that this market requires not just Democratic control but specifically 235+ House seats, which is a high bar — that's a net gain of ~20 seats, well beyond the minimum needed for a majority. Historical midterm waves against the president's party average around 25-30 seats (2018 was 41), but the research notes the district map is tilted toward Republicans and redistricting battles are ongoing. The Senate component also requires 51+ seats, which is challenging given the map. Favorable factors include strong Democratic enthusiasm, Trump's low approval with independents, and record primary turnout in states like Texas. Negative factors include a massive Republican financial advantage ($389M vs. Democrats), ongoing redistricting that could neutralize Democratic gains, and potential voting rule changes. The 7-day price drop of 3% suggests slight cooling of optimism. I'm adjusting slightly below the market price to 42%, reflecting that the 235-seat threshold is genuinely ambitious even in a wave environment, and the conjunction of both House AND Senate thresholds being met adds additional difficulty.

The Kalshi market prices this at 50%, down 12% over the past week. Key facts: Before the Supreme Court struck down IEEPA tariffs in mid-February 2026, tariff revenue was on a massive pace — $124 billion collected through January 2026 (304% increase YoY), with $30 billion in January alone. At that pace, full-year revenue would easily exceed $200 billion. However, the Supreme Court ruling eliminated the IEEPA tariffs, and Trump replaced them with a 15% global tariff under Section 122, which likely generates significantly less revenue than the prior regime (which had rates of 25-50% on many goods). If we assume ~$134B collected pre-ruling (through mid-Feb) and roughly 10.5 months remaining with lower tariff rates, the replacement 15% global tariff plus existing non-IEEPA tariffs (steel, aluminum, autos, Section 301) might generate roughly $8-10B/month — potentially yielding $85-105B for the remainder of the year. This puts total 2026 revenue in the $220-240B range if no refunds are subtracted, but potentially below $200B if significant refunds (up to $175B mentioned) are processed. The refund question is crucial — if refunds are netted against 2026 revenue, it could push well below $200B. The 7-day decline of 12% likely reflects growing uncertainty about refunds and the lower replacement tariff rates. I align closely with the market at 48%, slightly below 50% given the downward trend and refund risk.

The Kalshi market prices this at 31%, but I believe this significantly overestimates the probability. The evidence strongly suggests the US is achieving its Panama Canal objectives (removing Chinese influence) through diplomatic and legal channels rather than direct takeover. Panama's Supreme Court voided CK Hutchison's concessions, which is described as a 'major victory' for Trump - meaning the administration is getting what it wants without seizing the canal. Taking actual control of sovereign Panamanian territory would be an extraordinary act - essentially an invasion or forced annexation of a democratic ally - with no historical precedent in the modern era and massive international legal/diplomatic consequences. The market price likely reflects speculative interest driven by Trump's rhetoric rather than realistic probability assessment. No credible reporting suggests actual planning for a takeover. I deviate substantially from the Kalshi price because: (1) Trump's rhetoric about the canal was primarily about Chinese influence, which is being resolved diplomatically; (2) seizing sovereign territory from a treaty ally would be unprecedented and face enormous institutional resistance; (3) the US military and State Department would strongly oppose such action; (4) Kalshi political markets on sensational topics tend to be inflated by retail speculation.

The Kalshi market prices this at 24%, but I believe this is significantly too high given the evidence. Formal elimination of the Department of Education requires legislation passing both chambers of Congress, including 60 Senate votes (to overcome a filibuster), which means substantial Democratic support. No Democratic senator has shown any willingness to vote for this. While the Trump administration is aggressively hollowing out the department through staff reductions and transferring functions to other agencies via interagency agreements, every factual report confirms these moves do NOT constitute formal elimination. Education Secretary McMahon herself acknowledges congressional action is required. Congress has taken virtually no steps toward elimination legislation. The question asks about formal elimination ('sunsetted or eliminated entirely'), not functional degradation. Even with Republican control of Congress, the 60-vote Senate threshold is a near-insurmountable barrier. Historical precedent shows that no cabinet-level department has ever been formally eliminated. I deviate substantially from the market price because I believe the market may be conflating functional dismantlement with formal elimination, or overweighting the political rhetoric versus the legislative reality.

The Kalshi market prices the 'purchase' of Greenland at 26.3%, but I believe this is significantly overpriced. Every piece of evidence points strongly against a purchase: Denmark and Greenland firmly reject selling, Greenland's population opposes US acquisition, European allies have united in support of Greenland's sovereignty, and even Trump advisers prefer negotiation leverage over actual acquisition. The Vance-Rubio meeting with Danish/Greenlandic officials ended in 'fundamental disagreement.' The related Kalshi market for 'No Acquisition' is at 76%, and 'US takes control of any part' is at 36% (which includes non-purchase scenarios like military bases or agreements). A formal purchase requires willing sellers — Denmark and Greenland — and there is zero indication either would agree. Historically, sovereign territory purchases between Western nations haven't occurred in over a century, and the political/legal barriers are enormous (Danish parliament approval, Greenlandic referendum, likely constitutional issues). The market price likely reflects speculative interest and the general unpredictability of the Trump administration, but the structural impossibility of a purchase without consent from parties who categorically refuse makes this extremely unlikely.

The Kalshi market shows 23% but this seems significantly overpriced given the fundamental mechanics required. Impeachment requires a House majority vote AND a two-thirds Senate conviction (67 senators). Even in the best-case scenario for Democrats — winning the House in 2026 — they would still need 67 Senate votes to convict, meaning roughly 16-17 Republican senators would need to defect. The articles confirm: (1) Democrats aren't even prioritizing impeachment, (2) the 2026 House map is difficult for Democrats, (3) Senate Republicans show zero appetite for checking Trump. Historically, no president has ever been removed via impeachment. Trump was impeached twice before and acquitted both times with far fewer Republican defections than needed. The 23% Kalshi price likely reflects speculative/retail trading rather than calibrated probability — the volume is moderate but this is a long-duration novelty market prone to mispricing. I estimate ~3%, accounting for extreme tail scenarios like criminal revelations so severe they could fracture Republican loyalty, but even Nixon resigned rather than face certain removal.

The Kalshi market prices this at 12%, but I believe this is significantly overpriced. The US acquiring any part of Canada would be an unprecedented event requiring either military conquest of a NATO ally, a negotiated purchase/cession (which no Canadian government would agree to), or Canadian territorial secession followed by US annexation. All research evidence through March 2026 shows Canada actively strengthening sovereignty and deepening ties with the EU, with US-Canada disputes remaining firmly in the trade/tariff domain. The Alberta secession market at 17% is itself speculative, and even if Alberta voted to secede, the path from referendum to actual US acquisition involves many additional unlikely steps. Historical base rate for peaceful territorial acquisition of developed democracies is essentially zero in the modern era. The remaining ~3 years is insufficient for such a radical geopolitical shift. I deviate substantially from the 12% market price because I believe these political novelty markets tend to be inflated by speculative interest and the salience of Trump's rhetoric about Canada.

The Kalshi market for this specific question prices acquisition at 36%, but there's a notable discrepancy: the related 'No Acquisition' price market sits at 76% (implying only 24% chance of acquisition), and the 'Will Trump buy Greenland' market is at 26.3%. The 36% figure on this market seems inflated compared to the related markets. All evidence strongly points toward NO: Greenland's PM insists sovereignty is non-negotiable, the Vance-Denmark meeting ended in 'fundamental disagreement,' Europe has drawn explicit red lines, Greenlanders themselves broadly reject U.S. acquisition, even Trump advisers are divided on approach, and there's no concrete policy mechanism in place. The rhetoric has softened from military threats to 'framework of a future deal' talk, suggesting an off-ramp rather than actual acquisition. Given the enormous diplomatic, legal, and political barriers—including NATO alliance implications, international law, Greenlandic self-determination, and unified European opposition—and that we're looking at a ~3-year window, I weight the more consistent related markets (24-26% range) and then adjust downward further because the evidence overwhelmingly points to no acquisition. Historical base rate for peaceful territorial transfers of this magnitude in the modern era is essentially zero.

The Kalshi market prices this at 19%, but all available evidence strongly points against resignation. Every single article (10/10) indicates Trump is deeply engaged in governing, pursuing aggressive policies (Iran war, domestic changes, midterm strategy), and showing no signs of wanting to leave office. He is actively planning long-term projects and delivering State of the Union addresses. Historically, only one president (Nixon) has ever resigned, and that was under imminent removal threat. Trump's personality and behavior pattern strongly suggest he would never voluntarily resign — he didn't resign during his first term despite two impeachments. The 19% market price likely reflects speculative tail risks (health at age 78-82, potential deal-making scenario, legal pressure) plus some noise from retail traders. However, even accounting for legitimate tail risks over 3+ remaining years (health emergency, cognitive decline), 19% seems too high given the complete absence of any signals pointing toward resignation. I'm adjusting down to 10%, which still accounts for genuine low-probability scenarios like serious health events over the remaining ~3 years of the term.

The Kalshi market prices this at 12%, but the evidence strongly suggests even that is too high. Manufacturing's share of GDP has been on a secular decline for decades—it was around 11-12% before Trump's tariffs and has shown no signs of reversal. The question requires reaching 13.1%, a level not seen since 2005. Every piece of evidence points in the wrong direction: manufacturing employment has declined since tariffs were imposed, tariffs on key inputs (steel, aluminum, copper) have raised costs for domestic manufacturers, the Supreme Court struck down Trump's emergency tariff authority, and overall GDP growth is weak. Even localized manufacturing revivals are described as barely registering in national economic data. Reaching 13.1% would require an unprecedented ~2+ percentage point increase in manufacturing's GDP share within ~3 years—something that hasn't happened in modern U.S. economic history. I deviate below the Kalshi price of 12% because the market volume is relatively low (145 contracts/day) and the accumulated evidence since the market opened is overwhelmingly negative for this outcome.

The Kalshi market shows 73% probability, but I believe this is significantly overpriced. EU accession is an extremely lengthy process requiring unanimous approval from all 27 member states, completion of 35 negotiating chapters, and extensive legal/institutional reforms. The most advanced candidates are Montenegro and Serbia, but neither has closed all chapters - Montenegro has opened 33 but closed only 3, and Serbia has opened 22 and closed 2. Ukraine and Moldova received candidate status in 2022 but are years away from membership. No country has completed accession in under 8 years historically, and the current political environment (skepticism in some member states, rule-of-law concerns) makes fast-tracking unlikely. The EU has discussed reforms to its enlargement process, but concrete accession by January 1, 2030 would require unprecedented speed. Even with geopolitical motivation around Ukraine, full membership by 2030 is extremely unlikely. The Kalshi market has relatively low volume (75 contracts/day) suggesting the price may not be well-calibrated. I deviate substantially from the market price because the structural barriers to EU accession before 2030 are very high based on historical precedent.

The Kalshi market prices this at 32%, but I believe this significantly overstates the probability given the evidence. The most critical piece of information is Musk's February 2026 announcement that SpaceX is pivoting to prioritize the Moon over Mars, stating Mars efforts would begin 'in about five to seven years' — meaning 2031-2033 at earliest. As of late 2025, Starship had not yet achieved orbit, orbital propellant transfer, or full reusability — all prerequisites for a Mars mission. NASA was even considering dropping SpaceX from lunar lander contracts due to delays. Mars launch windows occur roughly every 26 months; the next windows are late 2026 and early 2029. A late 2026 launch is essentially impossible given current development status and the Moon pivot. A 2028-2029 window launch would require SpaceX to develop, build, and test a Mars-capable Starship variant, solve EDL for Mars (never done at this scale), and execute — all while prioritizing Moon missions. The technical challenges are enormous and SpaceX's own leadership has deprioritized this. I deviate substantially below the 32% market price because the February 2026 pivot announcement is strong, concrete evidence that this won't happen before 2030.

The Kalshi market prices this at 48%, but I believe this is significantly overpriced based on the evidence. For a humanoid robot to walk on Mars before 2035, someone would need to: (1) develop a humanoid robot capable of surviving Mars conditions, (2) build and test a rocket capable of delivering it to Mars, (3) successfully land it on Mars, and (4) have it walk on the surface — all before any human arrives. The evidence overwhelmingly points against this: SpaceX's Starship is still in early testing, Musk has pivoted priorities to the Moon, NASA's focus is entirely lunar with Mars as a distant goal, and every humanoid robot company (Tesla Optimus, Boston Dynamics Atlas, Chinese firms) is focused exclusively on terrestrial factory/home applications with zero space exploration programs. No space agency or company has announced plans to send a humanoid robot to Mars. Mars rovers use wheels because walking is enormously more complex and energy-intensive — there's no practical reason to send a humanoid walker. The ~9-year timeline to 2035 is far too short given current rocket and robot development states. The market at 48% likely reflects speculative interest and Musk hype rather than technical reality. I deviate strongly from the market price because the evidence is uniformly negative with no countervailing signals.

The Kalshi market prices this at 34%, but I believe this is significantly overpriced. The key ambiguity is what 'nuclear fusion is achieved' means - if it means commercial fusion power, every single source confirms this is not happening before 2030 (earliest timelines are 2031+). If it means net energy gain in a lab, that was already achieved at NIF in December 2022. The market likely reflects uncertainty about the resolution criteria. However, given that: (1) all 10 research articles uniformly point to NO direction, (2) the 30-day price trend shows a dramatic -15% decline suggesting the market is correcting downward, (3) Commonwealth Fusion's SPARC hasn't demonstrated net energy yet and their commercial plant targets early 2030s, and (4) TAE explicitly targets 2031 for their first plant, the probability should be well below the current market price. I set 12% to account for some small chance that SPARC or another experiment achieves a dramatic net-energy milestone that satisfies whatever resolution criteria is used, or that the question resolves on a looser definition. The market's 34% seems to reflect retail speculation rather than informed assessment.

The Kalshi market prices this at 21%, but I believe this significantly overestimates the probability. The resolution criteria require a 'self-sufficient colony of at least 10 people' residing on Mars for 'at least one Earth year' before Jan 1, 2050. This is extraordinarily demanding — it means not just landing humans on Mars, but sustaining 10+ people self-sufficiently for a full year, all by 2049 at the latest. As of late 2025, Starship hasn't achieved orbit reliably, orbital refueling hasn't been attempted, no crewed deep-space mission with Starship has occurred, and even returning to the Moon is years behind schedule. The related market showing only 9% chance Musk visits Mars in his lifetime is far more consistent with reality. A realistic timeline: first uncrewed Mars landing ~2030-2032, first crewed landing ~2035-2040 at earliest, and a self-sufficient 10-person colony sustaining for a year would require massive additional infrastructure well beyond that. The 25-year window to 2050 is simply insufficient given current technology readiness, repeated Starship failures documented in 2025, and the enormous gap between landing humans and establishing self-sufficiency. I deviate substantially below the market price because the market likely conflates 'landing on Mars' with the much harder 'self-sufficient colony' criterion.

The Kalshi market prices this at 8%, and the evidence strongly supports a low probability. Despite DOGE's aggressive push and a historic government shutdown, Treasury data shows federal expenditures actually increased by hundreds of billions compared to the prior year. Mandatory spending (Social Security, Medicare, debt service) continues to grow and dominates the budget, making a $250B net decrease nearly impossible without legislative reform. Musk himself called DOGE only 'a little bit successful,' agencies are rehiring workers, and the related market for government spending increasing by $400B+ in 2026 sits at 66%, which is directly contradictory to spending cuts. The longer-horizon market (cuts by end of term) is even lower at 6%, suggesting the market sees this as extremely unlikely. I shade slightly below the 8% current price given the strong factual evidence that spending is rising, not falling.

The Kalshi market prices this at 8%, but I believe even that is too high. All available evidence shows Trump's strategy is focused on pressuring the Fed on interest rates and replacing its leadership (Powell's term expires May 2026), not abolishing the institution. Ending the Federal Reserve would require an act of Congress repealing the Federal Reserve Act — an extraordinarily heavy legislative lift with no meaningful congressional support. The judiciary is actively blocking even modest encroachments (quashing subpoenas), former Fed chairs from both parties are defending the institution, and the Supreme Court allowed board member Cook to remain. There is no historical precedent, no proposed legislation, and no plausible mechanism for ending the Fed before January 2029. The 8% Kalshi price likely reflects speculative retail interest and the novelty/entertainment value of the market rather than genuine probability. I discount significantly to 3%.

The Kalshi market prices this combo at 79.5% with reasonable volume (~1049 contracts/day) and a strong upward trend (+13.5% over 30 days). The question requires BOTH Democrats winning 218+ House seats AND holding 49+ Senate seats. The House component appears to be the more likely leg - Democrats need only 3 net pickups, midterm opposition party tailwinds are strong, and 2025 off-year results showed significant Democratic overperformance. The Senate leg (49+ seats) means Democrats can lose at most 2 of their current seats (they hold 47 + 2 independents = 49 effective seats), or need to offset losses with pickups. The Senate map is challenging but Democrats have few seats truly at risk and some pickup opportunities. Research articles consistently show strong Democratic enthusiasm, Trump disapproval driving opposition turnout, and favorable midterm dynamics, though redistricting and a narrow competitive map create uncertainty. I'm pricing this very slightly below the market at 0.78, as the conjunction of both conditions introduces meaningful risk - the Senate retention requirement adds a non-trivial failure mode even if the House flip is likely.

The Kalshi market prices this at 12%, but I believe this is significantly overpriced. Every piece of evidence shows the U.S.-Canada dynamic involves trade disputes and tariff negotiations, not territorial acquisition. Canada is actively diversifying away from U.S. dependence (EU ties, China/India outreach), showing zero willingness to cede territory. There is no legal mechanism, no negotiation, no Canadian political will, and no realistic military scenario for the U.S. acquiring any part of Canada before January 2029. Trump's rhetoric about Canada as the '51st state' has been trolling/leverage for trade deals, not a serious policy initiative - his focus shifted to Greenland. The Alberta secession market at 17% is relevant but even if Alberta voted to secede (extremely unlikely), joining the U.S. would require additional steps far beyond the timeframe. Historically, democratic nations don't cede territory to other democracies through coercion. The 12% Kalshi price likely reflects speculative interest and meme-trading rather than genuine probability assessment. I deviate substantially downward because the base rate for territorial acquisition between allied democracies in the modern era is effectively zero.

The Kalshi market prices this at 16%, trending downward (-3% over 7 days, -7% over 30 days), suggesting the market sees declining probability. While China's late December 2025 military drills ('Justice Mission 2025') were the most extensive ever - including live-fire exercises, missile launches, and simulated blockades - the U.S. did NOT issue a Level 4 advisory even during those drills. The March 2026 U.S. intelligence assessment explicitly concluded an imminent Chinese attack is unlikely, and the Trump administration appears to view Taiwan as a negotiating chip rather than an imminent crisis. Historically, Level 4 ('Do Not Travel') advisories are reserved for active conflict zones or extreme danger (e.g., North Korea, Syria, Iraq), and Taiwan currently has Level 1 (normal precautions). Jumping from Level 1 to Level 4 without an actual military conflict would be unprecedented. The downward market trend reflects the fading of the December drill scare without escalation. I shade slightly below the market at 14% given the strong evidence that even major provocations haven't triggered advisory changes and the updated intelligence assessment.

The Kalshi market prices this at 63%, up significantly (+17% over 7 days) but with relatively low volume (130 contracts/day). Key facts: Through early February 2026, tariff revenue was already $124 billion (with $30B in January alone), running at a pace far exceeding $200B annually. However, the Supreme Court struck down IEEPA tariffs in mid-February, which were the primary driver of this surge. The replacement is a 15% global tariff under Section 122 (vs. the prior ~17% average rate under IEEPA), dropping effective rates to roughly 7-15%. Additionally, potential refunds of up to $175 billion on previously collected IEEPA tariffs could devastate net revenue figures. The critical question is whether 'tariff revenue' means gross collections or net of refunds - if refunds are processed in 2026, this likely resolves No. Even without refunds, the post-ruling tariff rate is substantially lower. With ~$124B already collected by early February under the old regime, the remaining ~10 months at the lower rate might generate $80-120B more, potentially reaching $200-244B gross. But refund risk is substantial and creates significant downside. I shade slightly below the market at 58% given the refund uncertainty and the fact that Section 122 tariffs expire in 150 days unless Congress acts.

The Kalshi market prices this at 52%, but I find reasons to shade somewhat lower. As of late 2025, U-3 unemployment was 4.6% - still far from 9%. Reaching 9% would require unemployment to roughly double, which historically has only happened during severe recessions (2008-2009 GFC peak was 10%, 2020 COVID peak was 14.7%). The evidence shows a softening labor market and some negative shocks (prolonged government shutdown, Iran war in early 2026 creating global uncertainty), but no signs of a catastrophic collapse. However, the 4.5-year window through January 2030 is long, and there are genuine tail risks: trade war escalation, geopolitical shocks, and policy uncertainty could compound. The market's 52% price seems slightly high given that even with the concerning developments, reaching 9% requires a severe recession-level event, which occurs roughly 2-3 times per decade historically but doesn't always push unemployment that high. I'm adjusting down to 40%, reflecting that while tail risks are real over this timeframe, the current trajectory and distance from 9% make it more likely than not that unemployment stays below that threshold.

The current Kalshi price for this market is 44%, which I'll use as my primary anchor. As of December 2025, the fed funds rate was 3.50%-3.75% after three cuts totaling 75bps in 2025. The question asks whether the upper bound will be ABOVE 3.25% by March 2027 - meaning the rate needs to stay relatively high or not be cut too aggressively. The research articles from late 2025 generally point toward continued rate cuts in 2026, with some forecasters expecting rates to fall below 3%. However, the 7-day price change of -21% suggests a significant recent shift toward expecting more cuts (i.e., rates falling to or below 3.25%). The related Jan 2027 market shows 40% for above 3.25%, which is slightly lower than the March 2027 market at 44% - this is somewhat inconsistent since if rates are cutting, March should be equal or lower than January, not higher. The 28% chance of zero rate changes before 2027 suggests most expect at least some cuts. Starting from 3.50%-3.75%, it would take only 2-3 additional 25bp cuts to bring the upper bound to 3.25% or below. Given the expected cutting trajectory but uncertainty around tariff-driven inflation and economic conditions that could pause cuts, I'll stay very close to the market price at 0.43.

The Kalshi market prices Deel IPO before Jan 1, 2027 at 23%, down sharply (-29% over 7 days, -15% over 30 days), indicating rapidly declining confidence. No research articles mention Deel specifically or any concrete IPO plans. The related market shows Deel is favored to IPO before Rippling (73%), but that's about relative ordering, not timing. The significant downward trend in the main market suggests new information or reassessment has occurred making an IPO in the remaining ~6 months less likely. With no positive signals about Deel IPO preparations and the market moving strongly downward, I anchor closely to the current market price at 22%.

The Kalshi market directly prices this event at 68%, which is my primary anchor. The evidence supports this: the Fed held rates in January and March 2026, inflation remains above target at 2.7%, geopolitical uncertainty (Iran war) is creating a hold-steady environment, and the Fed is deeply divided - all factors favoring a 0bps hold. The related market showing 28% chance of exactly 0 rate changes before Jan 2027 implies ~72% chance of at least one change, but that doesn't contradict a hold at the specific January 2027 meeting. The 'above 3.50% after April 2027' market at 51% suggests rates may still be relatively elevated, consistent with limited cutting. The current fed funds rate is likely around 4.00-4.25%, and with persistent inflation and geopolitical risks, a hold at the January 2027 meeting is the most likely single outcome but far from certain - there's meaningful probability of cuts having occurred by then or a cut at that specific meeting. I see no strong reason to deviate from the market price.

Current CO2 is at ~430 ppm as of mid-2025. The question is whether it reaches 440 ppm before January 2030. Recent annual CO2 increases have been approximately 2.5-3 ppm/year, with 2024 seeing the largest year-over-year increase ever recorded. At 2.5 ppm/year from 430 ppm, we'd reach 440 ppm around mid-2029; at 3 ppm/year, we'd reach it by early 2028. However, CO2 has seasonal variation (peaks ~May, troughs ~September), with the annual peak typically ~3-4 ppm above the annual mean. So the peak in May 2029 could plausibly reach 440 even if the annual mean is slightly below. The Kalshi market is at 86% and has been declining (down 9% over 30 days), suggesting some uncertainty. The key risk to 'No' is that the question says 'at least 440' — it's unclear whether this refers to peak, monthly average, or annual average. If it requires the annual average to hit 440, that's harder (likely needing ~4.5 years at current rates from a 2024 annual mean of ~426-427). If it's any monthly reading, it's much more likely. Given this ambiguity and the market's recent decline from 95% to 86%, I slightly discount from the market price to 82%, reflecting genuine uncertainty about whether CO2 growth rates will sustain the highest recent pace and resolution criteria details.

The Kalshi market prices this at 7%, trending down (-4% over 7 days). This question requires multiple compounding conditions: (1) crewed Mars missions must become technologically feasible, (2) Musk must personally go (not just send others), and (3) Musk must survive long enough (born 1971, he'd be 127 by 2099 - but realistically the window is more like 20-30 years before age/health becomes prohibitive). Recent evidence is mostly negative: SpaceX has pivoted priority to the Moon, Starship is still in early testing without key milestones like orbital refueling, and NASA contracts are in jeopardy. Even the related market for any human landing on Mars before 2050 is only at 25%, and Mars colonization before 2050 is at 16%. For Musk personally to visit Mars, humans must first get there, then the mission profile must allow a non-professional-astronaut billionaire to go (plausible given his ownership of SpaceX), and he must be alive and healthy enough. Given the long time horizon to 2099, there's meaningful probability humans reach Mars eventually, but the requirement that Musk specifically goes adds substantial conditionality. I slightly shade below the market at 6%, reflecting the recent negative trend and the pivot away from Mars toward the Moon.

The Kalshi market prices this at 67%, which I'll use as my anchor. The evidence largely supports Blue Origin having a plausible path to landing on the moon before SpaceX lands an uncrewed Starship. Key factors favoring YES: (1) Blue Origin is redirecting resources from New Shepard to focus on Blue Moon development, (2) SpaceX's Starship faces major unresolved technical hurdles including orbital refueling, (3) NASA has restructured Artemis with additional preparatory missions pushing Starship timelines back, and (4) NASA leadership has openly questioned SpaceX's Starship contract viability. However, Blue Moon MK1 is also unproven and faces its own development challenges - it's a smaller vehicle but still needs to demonstrate autonomous lunar landing capability. Musk's pivot toward Moon priority adds some competitive pressure. The contrarian case: SpaceX has far more launch cadence, iterates rapidly, and could potentially land an uncrewed Starship on the Moon without NASA's full Artemis architecture if they choose to self-fund a demonstration. I shade slightly below market at 0.65, acknowledging that while Blue Origin has structural advantages in this race, the market may slightly underweight SpaceX's ability to accelerate independently.

The Kalshi market prices US at 70% to be the next country to send humans to the Moon before 2031. The evidence strongly supports this: Artemis II (a crewed lunar flyby) is imminent as of early 2026, NASA has announced ambitious $20B moon base plans with multiple crewed landings per year, and there's strong political will (Trump's 2028 goal). However, the question likely requires an actual crewed landing, not just a flyby, meaning Artemis III or later must succeed before 2031. Key risks include SpaceX Starship delays for the lunar lander (significant technical challenges with in-orbit refueling noted as of late 2025), and China targeting 2030 as a competitor. The related Blue Origin vs SpaceX market (67% Blue Origin lands first) suggests the market sees real uncertainty about SpaceX's timeline, which could affect Artemis III scheduling. Given the market price of 70% seems well-calibrated to the balance of strong programmatic momentum against real technical and schedule risks, I see no strong reason to deviate from the market consensus.

The Kalshi market prices Judy Shelton's confirmation as Fed Chair at 2.2%, trending downward over both 7-day and 30-day periods. The research shows Powell's term expires May 2026 and Trump wants a loyalist replacement, but Shelton is not mentioned in any of the articles about potential successors. Shelton was previously rejected by the Senate for a Fed Board seat in 2020, making her confirmation as Chair even more unlikely. The highly contentious political environment around Fed independence, with bipartisan opposition from former Fed chairs and Treasury secretaries, would make confirming a controversial figure like Shelton extremely difficult. With decent volume (~74K daily contracts) and consistent low pricing (2-5% range), the market appears well-calibrated. I see no evidence to deviate from the market price.

The Kalshi market prices this at 10.2% and trending downward (-3.8% over 30 days). The evidence strongly supports a lower probability: the bill passed the House but faces an insurmountable 60-vote filibuster threshold in the Senate, with Senate Majority Leader Thune explicitly stating the votes aren't there. Democrats are uniformly opposed, and even the talking filibuster workaround lacks Republican support. Trump's demands to add controversial provisions (ending mail voting, transgender policies) further complicate passage. The only path would be eliminating the filibuster, which also lacks sufficient Republican support. With less than 7 months remaining and no realistic legislative pathway, I estimate slightly below the market at ~6%, as the market may still be pricing in a small tail risk of filibuster elimination or a dramatic political shift that seems very unlikely given current dynamics.

The most critical evidence here is that Capital One announced an acquisition of Brex for $5.15 billion in January 2026. This acquisition effectively eliminates any path for Brex to IPO independently, as it will be absorbed into Capital One. The Kalshi market currently prices Brex at 10%, which likely reflects some residual uncertainty about whether the acquisition could fall through (regulatory issues, deal collapse) and Brex could then pursue an IPO before Ramp does. However, the deal appears to be proceeding - Capital One has completed large acquisitions before (Discover Financial) and this is a much smaller deal. Even if the acquisition somehow fell through, Brex would need to IPO before Ramp, and there's no indication Brex was closer to an IPO than Ramp. I'm pricing slightly below the market at 5% because the acquisition seems very likely to close, making a Brex IPO nearly impossible.